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 ABSTRACT 
MECHANISMS OF NEURONAL DEATH INDUCED BY ENVIRONMENTAL TOXICANTS 
IN MURINE CORTICAL CULTURE 
 
 
Travis Rush, B.S. 
 
Marquette University, 2011 
This study was directed at examining the neurotoxic mechanisms of several classes of 
environmental toxicants implicated in neurodegenerative disease.  Primary cortical cultures were 
exposed to organophosphorus pesticides, heavy metals and the cyanobacterial toxin, beta-N-
methylamino-L-alanine (BMAA).  Several components relating to neuronal injury were assessed 
in each study and novel aspects are described. 
 
The main action of organophosphorous insecticides is generally believed to be the 
inhibition of acetylcholinesterase.  However, these compounds are now recognized to inhibit 
many other enzymes and cause neuronal death through a variety of mechanisms.  I found that 
exposure to chlorpyrifos or diazinon caused concentration-dependent neurotoxicity that could not 
be attributed to acetylcholinesterase inhibition.  Chlorpyrifos exposure increased extracellular 
glutamate and induced a diffuse nuclear staining characteristic of necrosis; the toxicity was 
sensitive to ionotropic glutamate receptor antagonists.  Diazinon toxicity was blocked by caspase 
inhibitors.  Additionally, diazinon induced punctuate chromatin staining characteristic of 
apoptosis.  These results represent two distinct, novel mechanisms of organophosphorous 
neurotoxicity. 
 
Heavy metals are ubiquitous in the environment and are of significant health concern 
worldwide.  Exposure to lead, iron, mercurials (inorganic mercury, methylmercury, or thimerosal, 
i.e. ethylmercury) or other heavy metals is implicated as a risk factor for neurodegenerative 
disease.  I found that the toxicity of these metals may be enhanced when interacting with 
chelators used to treat metal intoxication.  As well, my studies describe a new role for mercury-
induced oxidative stress as a cytoprotective signal to enhance glutathione levels.  My data also 
suggests an obligate role for MRP1 in the detoxification of methylmercury. 
 
Neurodegenerative diseases likely involve complex interactions between genetic 
predisposition and multiple environmental factors.  My final study tested the interaction of the 
methylmercury and BMAA.  Importantly, concentrations of BMAA that caused no toxicity by 
themselves potentiated methyl mercury toxicity.  BMAA plus methylmercury, at concentrations 
that had no effect by themselves, depleted cellular glutathione.  The combined toxicity was 
attenuated by glutathione monoethyl ester, and the free radical scavenger, trolox, but not by the 
NMDA receptor antagonist, MK-801.  The results indicate a synergistic neurotoxic interaction 
targeting the cellular redox state.  This finding may have implications for neurodegenerative 
disease caused by environmental toxicant exposure. 
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CHAPTER I 
 
 
 
 
 
 
 
 
 
GENERAL INTRODUCTION 
  
2 
General Introduction 
Given the prevalence of toxicants such as mercury and pesticides in our environment 
human exposure to these chemicals is ubiquitous.  Such exposures can cause damage to the 
developing and mature nervous system.  It has been hypothesized that damage from neurotoxicant 
exposure may account for subsequent onset and/or development of neurodegenerative diseases 
such as Alzheimer‟s Disease (AD), amyotrophic lateral sclerosis (ALS) and Parkinson‟s Disease 
(PD).  Of specific interest to this thesis, exposures to mercury, organophosphorous pesticides 
(OPs) and/or a cyanobacterial toxin known as beta-N-methylamino-L-alanine (BMAA), have 
each been implicated in development of one or more of the aforementioned neurodegenerative 
diseases.  The aim of this thesis is to identify mechanisms of toxicity effecting primary cortical 
cells for several environmental toxicants in order to better understand how these toxicants may 
trigger the onset of neurodegenerative disease.  Further, upon recognizing that many toxicants 
have overlapping cellular targets in the primary cortical neurons and glia, the aim expands to 
demonstrate synergistic toxicity exerted by combined insults.   
The data presented here identify that mercury compounds cause a redox imbalance 
concurrent with a loss of the major antioxidant to the central nervous system (i.e. glutathione) 
which is in agreement with previous reports.  Exposure to BMAA also led to a decrease in 
glutathione (GSH).  However, OP pesticides did not disrupt GSH levels.  These data are of 
particular relevance because of the historical implications of oxidative stress and disruptions of 
glutathione observed in patients afflicted with neurodegenerative disease(s).  The present studies 
provide novel information describing how mercury and BMAA disrupt GSH cycling between 
cortical astrocytes and neurons.  The following sections discuss these data and the implications in 
detail, as well as the synergistic toxicity observed when subtoxic methylmercury and BMAA 
insults are combined.  There is considerable evidence to suggest that certain populations (e.g. fish 
consumers) are likely to be exposed to both methylmercury and BMAA.  However, the greater 
3 
value of these data is to validate further investigation of combined toxicity.  While the present 
data strongly support a role for redox disruptions and glutathione deficiency in the development 
of neurodegenerative diseases following exposure to mercury and/or BMAA, it is important and 
interesting to note that evidence from the enclosed studies of OPs suggests a distinct mechanism 
that does not involve glutathione depletion. 
 
Environmental Toxins 
Pesticides 
Organophosphorous (OP) insecticides are the most commonly used pesticides in 
worldwide agriculture and industry.  OP pesticides are favored over their organochlorine 
predecessors, such as dichlorodiphenyltrichloroethane (commonly known as DDT), because OP 
compounds are more potent and they are designed to chemically degrade more rapidly when in 
soil and groundwater or when exposed to direct sunlight (for review: Eaton et al., 2008).  Despite 
this rapid degradation, however, significant quantities are often detected in food and water from 
rural sources (Ivey, 1979; Fenske et al., 2002).  Chlorpyrifos (CPF, sold under the tradenames 
LORSBAN and DURSBAN) and diazinon (DZN, sold under the tradenames Spectracide and 
Alfatox) are among the most widely used for their greater stability and persistence (Mileson et al., 
1998).  It is estimated that CPF itself is responsible for tens of thousands of deaths each year 
throughout the world (Gunnell et al., 2007), though it should be noted that the majority of these 
deaths are by self-intoxication meant to cause suicide (Eddleston et al., 2005).  Also, CPF has 
been documented as less likely to cause OP-induced delayed polyneuropathy (OPIDP, 
Richardson et al., 1993).  However, because OP pesticides are lethal, their sale for residential use 
has been banned in the US.  Despite this regulation, there remain significant stores sold prior to 
the ban, and many people continue to be exposed (Eskenazi et al., 1999; Whyatt and Barr, 2001; 
Whyatt et al., 2007; Adgate et al., 2009).   
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The concern for the acute neurotoxicity of these pesticides is largely due to the designed 
mechanism of action of OP agents.  These pesticides act much like their well-known weaponized 
partner compounds such as sarin, VX and tabun which are more potent.  The primary action of 
OP compounds, including CPF and DZN is to irreversibly inhibit acetylcholinesterase (AChE) 
enzymes throughout the nervous system (Mileson et al., 1998).  Such inhibition leads to 
accumulation of the neurotransmitter, acetylcholine (ACh), and subsequent overstimulation of 
cholinergic receptors at synapses in insects and humans, as well as at the neuromuscular junction.  
Such overstimulation, in humans, is clearly responsible for the cholinergic symptoms observed 
with acute exposure; these include seizures, pupil & bronchial constriction, convulsions and 
muscular fasciculations.  Ultimately, these muscle spasms lead to cessation of diaphragmatic 
movement causing death by respiratory failure (Mileson et al., 1998; Giordano et al., 2007).  
Importantly, and of great interest to this thesis, is that OP agents are known to inhibit many serine 
hydrolase enzymes (Casida and Quistad, 2005) and exert toxicity through several mechanisms (Li 
and Casida, 1998).  Also noteworthy, is that OP pesticides such as CPF and DZN do not produce 
significant inhibition of AChE until after being metabolized to their -oxon forms, chlorpyrifos-
oxon (CPO) and diazinon-oxon (DZO), respectively (Sams et al., 2004; Foxenberg et al., 2007).  
Despite this, CPF and DZN have been demonstrated to be neurotoxic without forming their –
oxons (Jett et al., 1999).  This is significant because there is wide variability of detectable CPO in 
the blood of individuals exposed to CPF; the variability is likely due to polymorphisms that have 
been identified in activating and deactivating enzymes that convert CPF to CPO, and is relevant 
to many other OP pesticides (Eyer et al., 2009).  For many years now, the central hypothesis for 
even low-level, chronic OP exposure leading to neurological dysfunctions has been aimed at 
understanding the anticholinesterase activity of these compounds, however, interest has now 
shifted to investigating the neurotoxic mechanisms independent of AChE inhibition (Garcia et al., 
2001; Costa, 2006). 
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Chlorpyrifos and other OPs have been shown to induce production of reactive oxygen 
species (ROS) leading to oxidative stress.  Acute, chronic and even developmental exposures to 
OPs have been clearly demonstrated to cause oxidative stress in animals, humans and in vitro 
studies (Banerjee et al., 2001; Abou-Donia et al., 2003; Kovacic, 2003).  Also, non-lethal OP 
exposure can decrease the antioxidant capacity (e.g. expression of antioxidant-related enzymes) 
in rat blood, liver and lungs, and in human brain (Akhgari et al., 2003; Bebe and Panemangalore, 
2003; Sharma et al., 2005).  Measures of lipid peroxidation have also indicated an oxidative 
mechanism of OP-induced toxicity (Verma and Srivastava, 2001; Oncu et al., 2002). 
Also supporting an oxidative stress mechanism is evidence of protection against OP 
toxicity with glutathione or antioxidant supplementation with an exogenous antioxidant, N-tert-
butyl-alpha-phenylnitrone (PBN), or catalase (Gultekin et al., 2001; Gupta et al., 2001).  In 
cerebellar granular neurons (CGNs) derived from mice lacking a glutathione-synthesizing 
enzyme, gamma-glutamate cysteinyl-synthetase (GCL), exposure to CPF or DZN caused 
heightened oxidative stress, lipid peroxidation and neurotoxicity over CGNs taken from wild-type 
mice (Giordano et al., 2007).  This study also provided evidence for increased disulfide (i.e. 
oxidized) glutathione levels without any change to total glutathione.  All of these effects were 
blocked by supplementation with exogenous, cell-permeant glutathione ethylester or catalase in 
the media.  Interestingly, the ACh receptor antagonists, atropine and mecamylamine, lacked 
protection, and the ACh receptor agonist, carbachol, was not toxic.  Taken together, these data 
suggest that the toxicity of these OPs does not involve a cholinergic mechanism. 
OPs are toxic to a multitude of cell types including non-excitable cells in brain and other 
tissues.  OPs induce apoptosis in oligodendrocyte precursors, cytotoxic T lymphocytes and cell 
lines including PC12 and C6 cells (Qiao et al., 2001; Caughlan et al., 2004; Saulsbury et al., 
2009).  CPF-induced cellular effects include an inhibition of cAMP production by adenylyl 
cyclase (AC) and an elevation of phosphorylated-CREB (pCREB, Huff et al., 1994; Schuh et al., 
2002) .  Elevated pCREB can be induced by CPF, CPO and the non-toxic CPF metabolite, 3,5,6-
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trichloropyridinol (TCP).  Since TCP increases pCREB and blocks cAMP production, a 
cholinergic mechanism is again, unlikely to be involved.  Decreased AC activity is thought to be 
responsible for additional inhibition of DNA synthesis and alterations to protein expression that 
have been reported (Garcia et al., 2001).  These genomic effects may be of particular interest 
when considering neurodevelopmental maladies induced by OP exposure. 
Embryonic and neonatal exposure to CPF is known to produce neurobehavioral 
abnormalities as well as locomotor, coordinate and cognitive deficits (Guillette et al., 1998; Terry 
et al., 2003).  Childhood exposure induces neurobehavioral changes as well (Ricceri et al., 2006).  
Initial studies into the mechanisms of OP-induced developmental effects found that OP agents 
inhibit neural replication, differentiation and can stunt neurite outgrowth (Li and Casida, 1998; 
Das and Barone, 1999).  CPF is also toxic to oligodendrocytes and their precursors and decreases 
myelin associated glycoprotein expression in these cells (Garcia et al., 2002).  Reduced 
myelination may account for many of the neurotransmission defects and the improper circuit 
connectivity observed later in animals exposed to OPs during early periods of development.  
Gross morphology alterations also result from perinatal OP exposures (Campbell et al., 1997; 
Roy et al., 2004).  Further alterations to expression of genes fundamentally involved in 
neurotransmission have been detected by genetic microarray studies (Slotkin et al., 2006; Slotkin 
et al., 2010).  These findings include downregulation of cholinergic receptors and mixed changes 
to glutamatergic signaling proteins (i.e. NMDA and AMPA receptors, among others).  Many of 
these effects are suggested to be independent of AChE inhibition.  The potential mechanisms of 
OP neurotoxicity are not mutually exclusive and are likely to act in concert to produce 
neurological deficits. 
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Heavy Metals 
Heavy metals are ubiquitous in the environment and are thus of significant concern.  
Acute exposures to high levels of Pb, Hg, Fe, Mn or other heavy metals are known to cause 
neurological damage and death.  Additionally, heavy metal exposure perinatally or during 
childhood is well-documented to cause severe deleterious neurological effects on the developing 
nervous system.  Further, chronic exposures to heavy metals, be they dietary, environmental (i.e. 
inhalation of pollutants) or occupational, have been implicated as major risk factors for 
neurodegenerative diseases (Mutter et al., 2004; Monnet-Tschudi et al., 2006; Praline et al., 
2007).  The following sections will introduce the historical and present knowledge surrounding 
several heavy metals of specific concern; incidence of exposure, neurodegenerative implications 
and cytotoxic mechanisms will be described primarily for mercurials.  Following these 
discussions, the practice of chelation therapy as well as its implications for human health will be 
introduced and potential reasons for concern in this field will be addressed.  
Mercury 
Mercury is perhaps the most frequently encountered of the heavy metals because of its 
multiple routes of human exposure.  The most common forms of concern for humans are 
elemental mercury (Hg), ethylmercury (EtHg) and methylmercury (MeHg).   Elemental mercury 
is usually inhaled as mercury vapor either in an occupational setting or having been released from 
amalgam dental restorations (Patterson et al., 1985; Bates et al., 2004).  Once the vapor is inhaled, 
the mercury easily passes into the blood stream and is rapidly ionized to form divalent (i.e. 
inorganic) mercury (Bjorkman et al., 2007).  The inorganic mercury then accumulates in the 
kidneys, liver and brain tissues (Hursh et al., 1976).  Ethylmercury is also presented to humans in 
the antifungal agent and bacteriocide, thimerosal.  Thimerosal has been and continues to be used 
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to preserve consumer products such as nasal sprays, dermal topical agents (e.g. tattoo inks), 
ophthalmic and otic products and is infamous for its inclusion in multi-use vials of vaccines 
(Elferink, 1999; Burbacher et al., 2005).  Administration of ethylmercury-containing vaccines has 
been of specific health concern for two main reasons.  First, direct intramuscular injection of 
ethylmercury gives the toxicant privileged access to the blood stream where it can readily cross 
the blood-brain barrier (BBB) (Mahaffey et al., 2004; Burbacher et al., 2005).  Second, many 
vaccinations are administered perinatally and during the early years of childhood, allowing 
ethylmercury to potentially exert damaging effects on the developing nervous system.  The latter 
concern led to a prolonged series of studies debating whether thimerosal exposure increased the 
risk of, or perhaps directly triggered autism in vaccinated children (Mutter et al., 2004).  This 
hypothesis has since been rejected by numerous epidemiological studies, and has been highly 
criticized for dissuading many concerned parents from providing their children with appropriate 
vaccinations (for review: Geier et al., 2007). 
For numerous reasons, the most concerning form of mercury is methylmercury (MeHg).  
MeHg is produced by aquatic bacterial methylation of elemental or inorganic mercury (Clarkson, 
1997).  The bacterial MeHg subsequently accumulates in fish and shellfish throughout the food 
web (Mahaffey et al., 2004).  Many of these mercury-contaminated species are later consumed by 
humans.  MeHg is readily absorbed in the GI tract and crosses the BBB easily (Kerper et al., 
1992).  While there is evidence that much of the MeHg is eliminated from the brain quickly, 
some of the MeHg is demethylated by astrocytes in the brain, leaving a mix of MeHg and 
inorganic mercury to accumulate with multiple dietary doses (Mahaffey et al., 2004).  Studies in 
primates and case studies in humans have demonstrated that a single episode of dietary MeHg 
leaves relatively little organic mercury but significant amounts of inorganic mercury detectable in 
brain many months after the exposure (Friberg and Mottet, 1989; Burbacher et al., 2005; 
Bjorkman et al., 2007). 
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Acute toxicity of methylmercury is also of great concern due to its use in manufacturing 
and industry.  Several incidents of widespread mercury poisoning due to industrial accidents have 
occurred in recent decades.  Severe neurological damage and many lethalities were reported 
following a major release of methylmercury into Minamata Bay, Japan (Harada, 1995; Tsuda et 
al., 2009).  Methylmercury-contaminated seed-grain farmed and consumed in Iraq produced 
similar reports in that population (Myers et al., 2000).   
Interestingly, many decades of research aimed at understanding the mechanisms of 
mercury toxicity have yielded limited conclusive results.  There are no ideal methods of treating 
mercury intoxication.  The data presented in this thesis strongly suggest that augmenting the 
endogenous glutathione system while addressing some other aspects of mercury-induced toxicity 
should be further investigated. 
 
Mercurial Toxicity Mechanisms 
Mercurials have long been documented to damage the CNS in humans and several animal 
species.  There have been many studies investigating the manner(s) by which mercury 
compromises neuronal health and function.  Major findings for mercurials are several-fold.  
Acute and chronic mercury exposure can disrupt neuronal signaling through actions on various 
ion channels (e.g. L-type calcium channels; Atchison and Hare, 1994).  Mercurials can cause 
swelling of astrocytes and compromise the integrity of the plasma membrane (Aschner, 2000).  
Intracellular release of calcium stores and zinc freed from proteins lead to cation dishomeostasis 
(Haase et al., 2009; Kawanai et al., 2009).  Membrane transport of excitatory amino acids, such as 
glutamate, has also been reported to be disrupted by the presence of mercurials (Allen et al., 
2001; Fonfria et al., 2005)  Common pathways for mercury induced toxicity also include the 
induction of oxidative stress through increased production of reactive oxygen species (ROS) and 
mitochondrial dysfunction (Ali et al., 1992).  Glutathione depletion also occurs and has been 
posited to result from the mercurial-induced oxidative stress (Yee and Choi, 1996; Sanfeliu et al., 
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2001).  Recently, the focus has been on these oxidative mechanisms and how they relate to 
protein oxidation/misfolding and neurodegenerative disease (Rooney, 2007). 
The focus on mercurial disruption of redox status has naturally turned to investigating 
glutathione, the major endogenous antioxidant in the mammalian nervous system.  Support for a 
role of glutathione is abundant.  It has been suggested that lower glutathione content accounts for 
the increased sensitivity of cerebellar granule neurons (CGNs) relative to cortical cells (Kaur et 
al., 2007; Wang et al., 2009).  In addition, glutathione precursors or exogenous glutathione are 
neuroprotective against mercurial insult when supplemented in vitro and have been reported to be 
effective in a rodent model (Fujiyama et al., 1994; Kaur et al., 2006; Toyama et al., 2007).  These 
findings have largely been suggested to be due to glutathione acting as an antioxidant.  However, 
some reports have suggested that glutathione directly conjugates with mercurials via disulfide 
bonds for which mercury has a great affinity (Rooney, 2007).  Importantly, studies have 
suggested antioxidant supplementation to be neuroprotective as well (Gasso et al., 2001; Shanker 
and Aschner, 2003).  However, as demonstrated and later discussed in this thesis, very few 
studies have demonstrated gross cyto-protection against mercurial insults with antioxidants 
despite the ability of these antioxidants to reduce mercurial-induced oxidative stress (Shanker and 
Aschner, 2003; Kaur et al., 2010).  In fact, my work provides evidence that reducing an early 
mercurial-induced oxidative response can potentiate subsequent neuronal death.  These data 
suggest that an early oxidative burst signals functional upregulation of a cytoprotective 
mechanism involving system xc
-
.  This allows for enhanced uptake of the glutathione precursor, 
cystine, and allows for greater detoxification of mercury in the cell.  Supporting this hypothesis is 
a recent study targeting a means of augmenting this system to provide cytoprotection against 
mercurial insult to hepatocytes and a neuronal cell line (Toyama et al., 2011). 
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Implications in Neurodegenerative Disease 
There exists strong evidence for mercury in the etiology of several neurodegenerative 
diseases.  Many case studies and several epidemiological studies have identified elevated blood 
levels of mercury in patients with AD, PD and ALS (Hock et al., 1998; Praline et al., 2007).  
Cerebrospinal fluid samples and post-mortem brain tissue analyses have also confirmed the 
presence of mercury among such patient populations (Perry and Hodges, 1999; Riedl and Honey, 
2008).  There is a positive correlation between total mercury exposure and risk for development 
of ALS (Monnet-Tschudi et al., 2006); ALS-like symptoms have been observed in people 3 years 
after acute exposure to mercury (Johnson and Atchison, 2009).  Recently, a study in the a SOD1 
G93A rat model of ALS found that chronic exposure to methylmercury hastens the onset and 
progression of gait abnormalities and hind-limb weakness in these animals (Johnson et al., 2011). 
Lead 
Lead exposure has also been implicated in AD, PD, and ALS.  Environmental exposure 
to lead is widespread.  Occupational or industrial use of the metal puts factory workers at high 
risk (Nagatsu and Sawada, 2005; Kokayi et al., 2006).  Many homes contain lead-based paints on 
their walls and window frames.  While presence of lead in homes is of particular concern for 
childhood exposure, often through ingestion, adults are also exposed to lead dust created by 
opening and closing of these lead painted windows.  Inhalation was also hazardous in the days of 
leaded fuel supplies for automobiles and many consumer products make use of lead-containing 
components.  Thus, human exposure to lead is quite common (for review: Monnet-Tschudi et al., 
2006). 
Lead is known to accumulate in bones, marrow, kidneys, liver and brain tissues (Kamel 
et al., 2008).  Its developmental effects are thoroughly documented and exposure of children to 
high levels of lead has been greatly reduced.  However, even low and moderate concentrations 
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are now being recognized as capable of producing subtle neurological deficits in children, and 
perhaps contributing as a risk factor for later development of neurological disease.  Chronic, low-
level exposure is considered a risk factor for AD as it can lead to increased amyloid-precursor 
protein (APP) expression later elevating levels of amyloid beta (Monnet-Tschudi et al., 2006). 
As seen with mercurials, lead has also been reported to cause oxidative stress and to induce 
reactive gliosis (an indicator of inflammatory response in the CNS) in vitro and in vivo. 
Chelation 
The current therapeutic strategy for treating heavy metal intoxication whereby body 
burden of these metals is elevated beyond safe levels, is to administer one of several chelator 
compounds that are designed to, bind, mobilize and eventually remove the exogenous metal(s) 
from the body.  In allopathic medical practice, this is reasonably effective at reducing the body 
burden of the offending metal by choosing an appropriate chelator, though this is not without 
complications.  That is, these chelators are known to have limited specificity for heavy metals and 
can themselves disrupt endogenous metal ion homeostasis (e.g. Zn+, Mg+, etc) causing toxicity, 
illness and even leading to injury to several organ systems (Flora and Pachauri, 2010).  An 
additional concern with the use of chelation is that the desired mobilization can lead to 
redistribution of the heavy metal to tissues, such as brain, where damage can be more severe 
(Andersen and Aaseth, 2002; Andersen, 2004). 
A more concerning use of chelators is that in the field of alternative medical practice for 
“chelation therapy.”  The principle concept behind the use of chelators is similar to that in 
allopathic applications in that chelation therapy is meant to remove toxic exogenous metals from 
the body that may be responsible for some health conditions (e.g. heart disease, AD, autism) 
(Barnes et al., 2008).  However, the employment of these chelators is less descriminate; the 
patient need not have knowingly been intoxicated by any specific heavy metal and little 
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consideration is made for which chelating compound is used.  The most common in this practice 
is EDTA.  The danger with this strategy is that without knowing which metal(s) to target, these 
chelators can be damaging.  Evidence in this thesis suggests that each chelator can alter the 
inherent neurotoxic properties of each heavy metal.  In some cases the chelator successfully 
reduces the metal-induced neurotoxicity, but more often, the chelator may exacerbate the insult.  
Given that chelation therapy is used to treat upwards of 66,000 people in a continuously growing 
industry, potentially damaging effects may not be of small consequence (Barnes et al., 2008). 
 
beta-N-methylamino-L-alanine 
Initial interest in beta-N-methylamino-L-alanine (BMAA) as a neurotoxin came when it 
was isolated from cycad seeds regularly consumed by the endogenous Chamorro people of Guam 
(Steele and Guzman, 1987).  These native residents of the Guam and those living throughout 
Western New Guinea have a higher incidence of ALS.  The Guamanian form of this disease is 
actually described as amyotrophic lateral sclerosis-parkinsonism dementia complex (ALS-PDC) 
or locally as Lytico-Bodig. Afflicted individuals experience symptoms of ALS, PD and AD 
(Duncan, 1992; Cruz-Aguado and Shaw, 2009; Johnson and Atchison, 2009).  The incidence of 
this disease was extremely high among the Chamorro people during the 1950‟s and 1960‟s.  
Many studies have aimed to identify the cause of this increased prevalence and several 
environmental neurotoxic hypotheses have emerged.  Interestingly, all such theories put forth 
have involved dietary intake of a neurotoxic chemical, many of them shown to be present in the 
flour derived from cycad seeds (Duncan et al., 1992; Tabata et al., 2008). One well supported 
hypothesis is that insufficient dietary calcium and magnesium coupled with high intake of 
aluminum and manganese disrupts endogenous metal homeostasis and leads to subsequent 
neurodegeneration (Yoshimasu et al., 1980; Durlach et al., 1997).  Cycasin, zinc, sterol 
glucosides are among the cycad-based neurotoxic chemical theories (Spencer et al., 1991; Duncan 
14 
et al., 1992; Tabata et al., 2008), but consumption of BMAA, the neurotoxic non-protein amino 
acid present in cyanobacteria within cycad seeds, is perhaps the most interesting and has garnered 
waves of interest through the decades of ALS-PDC research (Cox and Sacks, 2002; Duncan and 
Marini, 2006). 
Strengthening the BMAA hypothesis, injection of BMAA directly into brains of monkeys 
induced motor deficits similar to PD (Spencer et al., 1987).  However, the hypothesis lost 
momentum in 1990 when researchers realized that the cycad seeds were washed prior to 
consumption and that this washing was sufficient to eliminate much of the BMAA suggesting that 
unrealistic amounts of cycad flour would need to be consumed to reach toxic concentrations of 
BMAA (Duncan et al., 1990). 
In 2003, another potential source of BMAA was reported.  Fruit bats feed on cycad seeds 
which are symbiotically inhabited with cyanobacteria.  BMAA bioaccumulates from the 
cyanobacteria into the cycad seeds, then further up the food chain into the fruit bats.  Indeed, the 
fruit bats contain incredibly high levels of BMAA (Banack and Cox, 2003).  Interestingly, 
Chamorros first began eating fruit bats as a regular component of their diet during the 1940‟s 
when Guam was occupied by Japanese troops (Banack et al., 2006).  In subsequent decades, the 
fruit bat population dwindled correlating well with the timing of the subsequent decline in disease 
occurrence. 
While this story is intriguing, there is limited evidence for a causal relationship between 
BMAA and ALS-PDC.  Several animal model studies have been unable to demonstrate 
neurotoxicity even at high levels of intake (for review: Karamyan and Speth, 2008).  The early 
studies in monkey (and subsequent findings in chicks) required incredibly high exposure levels.  
However, despite the conflicting results with BMAA as a neurotoxin in various models, some 
additional findings in recent years have provided rationale for considerable concern beyond 
explaining Guamanian ALS-PDC.   
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There are now many reports of cyanobacteria throughout the world that contain BMAA.  
Accordingly, several of the ecosystems harboring such bacteria have displayed the propensity of 
BMAA to bioaccumulate throughout the food web (Esterhuizen and Downing, 2008; Brand et al., 
2010; Jonasson et al., 2010).  This suggests that BMAA may be of concern for much broader 
population, potentially across the globe.  Further support for such concern comes from studies 
that have reported detection of BMAA in brain samples from AD patients in Canada in addition 
to ALS-PDC patients of Guam (Murch et al., 2004b).  Importantly, BMAA was detected in 
neither patients that had died of non-neurodegenerative disease, nor those that had died of the 
genetic neurodegenerative disease known as Huntington‟s Disease.  However, subsequent studies 
performed by other research groups have failed to detect BMAA in these populations (Montine et 
al., 2005; Snyder et al., 2009), a fact that must be considered when assessing the BMAA 
hypothesis of ALS-PDC. 
 
Mechanisms of BMAA Toxicity 
 BMAA has long been known to produce excitotoxic neuronal death in culture and in vivo 
models.  Early studies in primates injected with BMAA demonstrated that BMAA could lead to 
neurological maladies similar to ALS and PD (Spencer et al., 1987).  However, very high 
concentrations were required to produce damage.  Our lab and others have also found that high 
concentrations into the low millimolar range of BMAA are required in vitro to cause significant 
acute toxicity.  We have since characterized the excitotoxic and several other distinct mechanisms 
by which BMAA produces injury in cultured cortical neurons.   
Specifically, electrophysiological studies from our lab have demonstrated that BMAA 
directly activates NMDA receptors as a glutamate analogue (Lobner et al., 2007).  Further 
investigation has unveiled that BMAA can also induce glutamate release, cause activation of 
mGluRs, inhibit cystine uptake and decrease glutathione availability.  Evidence suggesting these 
mechanisms contribute to BMAA-induced toxicity come from studies demonstrating that BMAA 
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inhibits system xc
-
 mediated 14C-cystine uptake (i.e. Na-independent and CPG-sensitive) and that 
BMAA drives glutamate release by this transporter.  Additionally, BMAA toxicity is partially 
sensitive to blockade by the NMDA receptor antagonist, MK-801.  Once the primary NMDAR-
mediated component is blocked, administration of either the mGluR-5 antagonist, MPEP, or the 
antioxidant, trolox can further block toxicity.  Almost complete blockade of BMAA-induced 
toxicity can be accomplished by combining all three agents, MK-801, MPEP and trolox (Liu et 
al., 2009).  These mechanisms are illustrated together in FIGURE 1.1. 
 Others have provided evidence for additional mechanisms of BMAA toxicity.  In 2006, 
Vyas et al., showed that BMAA can directly activate calcium-permeable AMPA/kainate channels 
on spinal motor neurons (Rao et al., 2006).  Another hypothesis is that BMAA may be 
misincorporated into proteins while being synthesized.  Such improper translation leads to an 
unfolded protein response and eventually results in apoptotic cell death.  While evidence for this 
occurring with levodopa, this has not yet been published to occur with BMAA (Rodgers et al., 
2006).  Further research is necessary to understand to what degree each mechanism contributes to 
BMAA toxicity. 
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FIGURE 1.1.  Mechanisms of BMAA neurotoxicity. 
This illustration demonstrates the toxic effects of BMAA on primary cortical cultures.  BMAA 
can directly activate NMDA receptors (NMDARs), or be transported via system xc
-
 on astrocytes 
causing elevated glutamate release and decreased cystine uptake.  The released glutamate (Glu) 
can then activate mGluR 5 receptors or NMDARs.  Decreased astrocytic uptake of cystine (C-C) 
leads to a depletion of glutathione (GSH) and limited availability of GSH for neurons.  With 
compromised glutathione cycling, the neurons become particularly vulnerable to free radicals 
(e.g. oxidative stress).  Activation of the glutamatergic receptors leads to cation dishomeostasis 
and an imbalance in the redox status of the cells eventually leading to neuronal death. 
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Combined Environmental Insults 
Considering the ubiquity of neurotoxicants in the environment, the risk of human 
exposure to multiple toxic agents is increasingly high.  While much progress in understanding 
neurotoxic compounds in the environment has been made by studying these toxicants in isolation, 
this does not accurately represent the exposure conditions people are likely to encounter.  
Expecting any person to suffer exposure to only a single neurotoxic environmental factor is a 
drastic oversimplification.  A more complicated scenario of concurrent or overlapping temporal 
exposures to multiple neurotoxicants is increasingly likely.  Genetic variation may render some 
individuals particularly susceptible to damage by certain toxic insults.  The complexity involved 
in studying multiple neurotoxicants and the possible interactions with individual genetic variation 
increases very quickly.  However, it is imperative to consider that multiple risk factors likely 
converge to produce a disease state.  Recent studies have begun targeting these interactions.  My 
work describes a potential interaction of the environmental neurotoxicants methylmercury and 
BMAA. 
 
Relevant Cell Physiology 
Oxidative Stress and Glutathione 
A common factor for all of the neurodegenerative diseases and neurotoxicants discussed 
in this thesis is the elevated production of reactive oxygen species (ROS) such as superoxide 
(
.
O2), hydroxyl radical (
.
OH) and hydrogen peroxide (H2O2) (Di Monte et al., 2002; Cui et al., 
2004).  These oxidative insults can be generated from disruption of the mitochondrial electron 
transport chain or by induction of NADPH oxidase activity (Adam-Vizi, 2005; Brennan et al., 
2009).  There is much evidence, historically, for mitochondrial involvement.  However, it has 
recently been posited that the data for mitochondria-generated free radicals are weak and may be 
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artifactual in light of the recent findings implicating NADPH oxidase as the primary source of 
damaging ROS (i.e. 
.
O2).  Because NADPH oxidase is localized to the plasma membrane, 
increased activity and production of 
.
O2 can readily damage the plasma membrane (i.e. via lipid 
peroxidation) and redox sensitive proteins.  Such damage can compromise membrane integrity 
leading to numerous deleterious effects (e.g. morphology changes, loss of chemical and ion 
gradients, cell swelling, and cell death).  Protein oxidation can lead to improper cross-bridge 
formation and subsequent misfolding/malfunction resulting in further cellular dishomeostasis.   
Further investigation is necessary to definitively determine the contribution of each potential 
source of oxidative stress in each neuropathology, though cell death in many systems has been 
clearly documented as a result of severe or prolonged oxidative stress. 
Normal cellular respiration and activity are known to produce ROS and the cell has 
endogenous mechanisms to detoxify these radicals.  In the mammalian nervous system, 
glutathione (and related enzymes) is the primary antioxidant, though catalase and superoxide 
dismutase also contribute to the reduction of endogenous ROS produced.  Glutathione (composed 
of glutamate, cysteine and glycine) is most widely recognized for its capacity as an antioxidant 
(AO); specifically, GSH detoxifies superoxide in a reaction catalyzed by glutathione peroxidase 
forming disulfide/oxidized glutathione (GSSG) and water.  As ROS formation increases, the ratio 
of GSSG:GSH also increases.  These reactions are accomplished by redox changes at the 
sulfhydryl group of the cysteine residue of GSH (Dringen and Hirrlinger, 2003).  The rate of de 
novo synthesis of GSH is limited by the rate of cystine uptake (Sagara et al., 1993).  Importantly, 
neurons of the CNS have limited capacity for cystine uptake, and are reliant primarily on 
astrocytes for the provision of (reduced) cysteine and cysteinylglycine (CysGly) for neuronal 
glutathione production (Dringen et al., 1999).  Astrocytes express high levels of excitatory amino 
acid transporters also capable of importing cystine as well as a recently described cystine-
glutamate antiporter known as system xc
-
 (Dringen, 2000; Lewerenz et al., 2006).  Once 
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cyst(e)ine enters the cell, it is combined with glutamate and then glycine in a multistep enzymatic 
process (Dringen et al., 2000). 
 Upon synthesis, GSH plays a role in a number of important cellular/physiological 
processes illustrated in FIGURE 1.2.  The simplest possibility is direct export of GSH to the 
extracellular media, a process accomplished via the ATP-dependent multidrug resistant protein 
(MRP) 1 (Hirrlinger and Dringen, 2005; Minich et al., 2006).  Intracellular GSH plays a role in 
the reduction of damaging ROS, forming GSSG (Shih et al., 2006).  This GSSG is also a 
substrate for MRP1-mediated export.  A third role for GSH is one that has historically been 
characterized in cancer research.  GSH acts to detoxify xenobiotics, such as chemotherapeutics, 
often through sulfhydryl interaction catalyzed by a class of enzymes known as glutathione-S-
transferases (GSTs; Johnson et al., 1993; Lu and Shervington, 2008).  The glutathione conjugates 
(GSx) are also exported by MRP1 (de Jong et al., 2001). 
 In the extracellular space, glutathione-based molecules (i.e. GSH, GSSG and GSx) are 
each handled differently.  GSH can remain as GSH or be broken down into its constituent amino 
acids or glutamate and the precursor cysteinylglycine.  CysGly can be imported by astroycytes or 
neurons via gamma-glutamyltranspeptidase (Dringen et al., 1997).  GSSG is reduced to its GSH 
components by an enzyme, GSH reductase.  The GSx conjugates may or may not be broken down 
for recycling but may be mobilized to the renal system for elimination from the body (Franco et 
al., 2007b). 
System xc
-
 
The importance of regulating extracellular signaling molecules, particularly 
neurotransmitters and excitatory amino acids cannot be overstated.  To this end, many enzymes 
and membrane-spanning transporters function to degrade or remove such signaling molecules 
from the synaptic, perisynaptic and extracellular spaces thereby facilitating precise cell-cell 
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communication.  Of specific interest to neurotoxicity and degeneration is the regulation of the 
primary excitatory neurotransmitter, glutamate.  Overstimulation of ionotropic and in some 
instances metabotropic glutamate receptors can lead to a calcium-mediated excitotoxicity (i.e. 
necrotic or apoptotic cell death) which involves oxidative stress.  While sodium-dependent 
excitatory amino acid transporters (EAATs) are localized to astrocyte processes surrounding 
synapses to efficiently remove glutamate and prevent spillover into the extrasynaptic space, 
another important mechanism known as system xc
-
 serves to regulate both glutamate and cystine 
concentration gradients by exchanging one intracellular glutamate for one extracellular cystine.  
As discussed previously, the imported cystine is primarily used for glutathione synthesis.  The 
exported glutamate has been posited to play a role in activating perisynaptic type 2/3 
metabotropic glutamate receptors on neurons thereby exerting inhibitory tone on 
neurotransmission at a particular synapse (Xi et al., 2002; Moran et al., 2005).  Additionally, it is 
known that system xc
-
 is primarily localized to extrasynaptic glial membranes with minimal 
expression in neurons (Lewerenz et al., 2006) and that AMPARs and NR2B-containing 
NMDARs are also expressed in extrasynaptic locations.  Thus, system xc
-
 may exert powerful 
influence over extracellular glutamate concentrations, synaptic transmission, and glutathione 
availability (Xi et al., 2002; Seib et al., 2011). 
Importantly, modulation of system xc
-
 activity can be damaging by both increased and 
decreased activity.  Increased activity releases glutamate and subsequently activates 
glutamatergic receptors; inhibition of the antiporter decreases the amount of cystine imported and 
therefore decreases glutathione synthesis/availability which leads to an oxidative stress-mediated 
neuronal death (Murphy and Baraban, 1990; Chung et al., 2005).  Since the antiporter has 
approximately the same affinity for import of cystine or glutamate, the direction of transport is 
largely determined by the concentration gradients of these amino acids.  If extracellular glutamate 
is elevated, cystine uptake can be greatly diminished causing oxidative stress-mediate toxicity 
referred to as „oxytosis‟ (Murphy and Baraban, 1990; Ratan et al., 1994).  This effect was initially 
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characterized in immature cortical cultures not yet expressing ionic glutamate receptors limiting 
their sensitivity to excitotoxic stimulation by glutamate.  However, it is likely that elevated 
glutamate concentrations act by these multiple mechanisms.  Not surprisingly, provision of 
glutathione by astrocytes overexpressing system xc
-
 can be protective against oxidative stress in 
neurons (Shih et al., 2006). 
Diminished activity of system xc
-
 has been hypothesized to contribute to schizophrenia as 
well as addiction (Baker et al., 2008; Kau et al., 2008; Gu et al., 2010).  Glutamate released from 
activated microglia via system xc
-
 was first shown to be excitotoxic to cerebellar granular neurons 
(CGNs) and oligodendrocytes (Piani and Fontana, 1994).  It was shown that microglia also 
release ROS that can inhibit glutamate transporters on surrounding cells thereby prolonging and 
exacerbating the insult (Domercq et al., 2007).  More recent research posited a role for increased 
expression of system xc
-
 in reactive astrocytes increasing excitotoxicity in a culture model of 
hypoxia (Fogal et al., 2007; Jackman et al., 2010).  Another interesting aspect of system xc
-
 as a 
mediator of excitotoxic injury is found in the field of glioma research.  Glial tumor cells express 
greatly elevated levels of xCT, the catalytic subunit (i.e. functional component) of the cystine-
glutamate antiporter, and are capable of drastically elevating extracellular glutamate levels in the 
presence of physiological concentrations of cystine (Ye and Sontheimer, 1998).  This elevated 
glutamate induces seizures and can lead to excitotoxic neuronal injury which promotes tumor 
growth by overcoming the spatial limitations imposed by the skull (Sontheimer, 2008).  The 
increased ability of glioma cells to import cystine is also to their great advantage as it provides an 
abundance of the glutathione precursor which confers chemoresistance in these cells and protects 
against oxidative insults (Lu and Shervington, 2008). 
There has been minimal investigation for a role of system xc
-
 in the pathogenesis of 
neurodegenerative disease.  Though, it has been implicated in neurodegenerative disease for its 
ability to elevate extracellular glutamate concentrations to excitotoxic levels (Piani and Fontana, 
1994; Qin et al., 2006).  In addition, diminished activity of the antiporter may decrease 
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glutathione available to reduce the oxidative stress as seen in several neurodegenerative diseases 
(Franco et al., 2007b).  There is some indication it may be involved in the etiology of AD.  xCT is 
suggested to be upregulated in brains of AD patients.  Microglia of patients with Alzheimer‟s 
Disease express high levels of system xc
-
, particularly surrounding amyloid plaques, perhaps due 
to the inflammation associated with the disease.  Rodents injected with amyloid beta or 
overexpressing mutant amyloid precursor protein (APP) also show this microglial characteristic 
(Qin et al., 2006).  It is not clear whether the increased system xc
-
 activity contributes to 
pathogenesis by elevating glutamate or if the upregulation serves to protect by providing cystine 
for glutathione synthesis.  Administration of the antioxidants alpha-tocopherol and selegeline 
prolongs survival in AD patients and retards progression of cognitive impairments, though other 
antioxidant trials have not had these effects (Sano et al., 1997; Adair et al., 2001).  N-
acetylcysteine (NAC) is a sulfhydryl-containting direct antioxidant and serves as a cystine pro-
drug capable of driving system xc
-
 activity.  NAC administration failed to significantly improve 
clinical AD measures in a study of probable AD patients (Adair et al., 2001).  It is not clear 
whether a non-significant trend of beneficial effects was due to NAC‟s ability to drive cystine-
glutamate exchange; further study is required. 
Few studies have investigated involvement of system xc
-
 in the pathogenesis of PD.  
Though, in a popular rodent PD model using 6-hydroxydopamine lesion of the nigrostriatal 
pathway, knockout of xCT protected substantia nigra neurons from the insult.  The protection 
observed in the knockout animals was due to lowered extracellular glutamate concentrations in 
the striatum (Massie et al., 2008; Massie et al., 2011).  This study suggests that increased system 
xc
-
 activity due to inflammation characteristic of this neurodegenerative disease may contribute to 
pathogenesis.  There have been no studies to assess function or expression of system xc
-
 in 
parkinsonian tissues. 
The story is similar for studies investigating the role of the antiporter in ALS.  While 
there are no direct studies of system xc
-
 in ALS model systems, there have been studies 
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investigating the effects of NAC supplementation in these models.  Similar to the AD studies, it is 
not clear whether the effects of NAC can be attributed to increased drive of the antiporter.  NAC 
reduces oxidative insult and prevents ROS-induced decreases in glutamate uptake in 
neuroblastoma cells expressing mutant G93A-SOD1, a gene associated with familial ALS 
(Beretta et al., 2003).  There is conflicting in vivo evidence in G93A-SOD1 rodent models 
demonstrating no effect or delayed onset and prolonged survival with NAC administration 
(Jaarsma et al., 1998; Andreassen et al., 2000).  In a clinical trial, no benefit was observed with 
NAC treatment, however, there was an indication that NAC effected ALS subpopulations 
differently.  That is, patients whose symptoms had started in their limbs exhibited prolonged 
survival with NAC relative to those patients receiving placebo.  Patients with a bulbar-onset of 
disease, which is known to be at least weakly benefited with the antiglutamatergic drug (i.e. 
antiexcitotoxic) riluzole, had decreased survival in this trial (Louwerse et al., 1995).  This 
suggests that system xc
-
 may play differential roles between these forms of ALS. 
ROS can act as a signal to upregulate antioxidant-related cell components including 
system xc
-
 and GSH synthesizing enzymes.  The nuclear factor (erythroid derived-2)-like 2 
antioxidant response element (NRF2-ARE) pathway is suggested to be responsible for this effect 
(Johnson et al., 2008; Vargas and Johnson, 2009).  Endogenous and exogenous oxidative stress is 
known to upregulate mRNA and functional activity of xCT, the catalytic subunit of system xc
-
 
(Dun et al., 2006; Mysona et al., 2009).  Also, cells with increased xCT expression are resistant to 
oxidative insult suggesting this upregulatory system is a protective mechanism that may be a 
viable therapeutic target in neurodegenerative diseases. 
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FIGURE 1.2.  Glutathione cycling between astrocytes and neurons.   
In the mammalian nervous system neurons rely on astrocytes for de novo synthesis of glutathione 
and glutathione precursor availability.  Astrocytes have enhanced ability to import cystine, the 
rate-limiting substrate for de novo glutathione synthesis.  In mixed cortical cultures cystine is all 
but exclusively taken up by astrocytes via system xc- whereby one extracellular molecule of 
cystine is imported in exchange for one intracellular molecule of glutamate (Glu) being released.  
The imported cystine is then reduced to two cysteine (C) molecules which are enzymatically 
converted to glutathione (GSH).  The newly synthesized glutathione can be utilized for a 
multitude of tasks or released to the extracellular media.  Upon export, the glutathione is 
degraded by extracellular enzymes into its precursor molecules which can then be imported via 
excitatory amino acid transporters (EAATs) and utilized by nearby neurons.   While the uses for 
glutathione are detailed in the text, the prominent attributes of glutathione include its ability to 
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reduce damaging free radicals to non-toxic substances and to detoxify the cell of exogenous 
agents by conjugation and export via multidrug resistance proteins (MRPs).  The provision of 
glutathione precursors by astrocytes is crucial for neuronal health because of the limited capacity 
of neurons to import cystine.  Importantly, cystine-glutamate exchange via system xc- not only 
facilitates glutathione synthesis but also contributes to neuronal activity and health by regulating 
glutamate levels in the extracellular/extrasynaptic media.  The glutamate released by xc- can 
activate extrasynaptic NMDA receptors (NMDARs) and metabotropic glutamate receptors 
(mGluRs).  Figure abbreviations: C = cysteine, C-C = cystine, GSH = glutathione, GLU = 
glutamate NMDAR = NMDA receptor, mGluR = metabotropic glutamate receptor, MRP1 = 
multi-drug resistance protein 1, EAATs = excitatory amino acid transporters 
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General Methods 
This brief section will introduce the most important aspects of the model system used for 
the work in this thesis.  First is an overview of the cortical culture method used, the advantages 
and the limitations.  Also described here is the assay for gross cell death by measuring the release 
of lactate dehydrogenase.  
Cortical Culture 
The cortical culture method used in these studies is based on a long-standing, well-
characterized model.  Specifically, cortical hemispheres are dissected from embryonic mice 
(gestational day 15), manually triturated, trypsinized and then plated on 24-well plates coated 
with poly-D-lysine and laminin in Eagle‟s minimum essential media containing 5% (v/v) heat-
inactivated horse serum and 5% (v/v) fetal bovine serum, 2mM glutamine and glucose (total 21 
mM).  The cultures are then maintained in 5% CO2 incubators at 37° C for ~2 weeks.  The 
cultures are prepared at ~8 cortical hemispheres per plate and contain ~250,000 neurons with an 
additional ~100,000 glial cells growing to confluency over the weeks in culture.  The process 
results in a system that recapitulates, in a simplified form, many key components of the intact 
cortex while allowing precise, relatively high-throughput manipulations of the local environment.  
Additionally, minimal change to the dissection and/or culturing method allows enrichment of one 
cell type over another.  By adding the mitotic inhibitor, cytosine arabinocide, to the growth media 
2-3 days after plating we can produce nearly-pure neuronal cultures.  Delaying the dissection 
until postnatal day 1 produces pure-glial cultures as the neurons become sensitive to our culture 
conditions and die.  While growing these cell types in relative isolation introduces some 
confounds by stepping further from the physiological setting, it allows certain inferences about 
neurons or glia to be made that would otherwise be masked. 
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Experiments in this system are generally performed on cultures at 13-15 days in vitro 
(DIV) for a variety of reasons.  The delay of ~2 weeks from the day of dissection allows the cells 
to differentiate and mature; neurons grow and prune neurites and dendrites producing functional 
synapses and glia extend processes to encompass and support this neuronal/synaptic activity as 
they do in vivo.  A photomicrograph of a typical mature culture exhibiting these features can be 
seen in FIGURE 1.3.  Neuronal and glial expression of important signaling proteins more closely 
matches the in vivo profile after this 2 week incubation (e.g. Neurons express NMDA receptors at 
~DIV 12). 
Unfortunately, this system also has some inherent drawbacks.  Considering that the 
cultures are only viable under these conditions for ~20 days, the ability to perform any long-term 
study is severely limited if not altogether preempted by this fact.  Also, despite the formation of 
synapses that mimic intact neuronal networks, there is neither specific nor consistent circuitry 
formed in the cortical cultures used.  Thus, conclusions regarding such pathways are better suited 
to cortical slice culture or other systems and cannot be drawn directly from studies in this culture 
system.  Therefore, all of the studies in this thesis were performed to completion within DIV 13-
15, with the majority being on the order of 6-24 hours duration from onset to data acquisition.  
These short exposure periods often require relatively high concentrations of the various 
pharmacological agents employed.  By nature of the limitations of these methods, it must be 
assumed that acute, high-intensity exposure conditions somehow mimic the chronic 
pathophysiological conditions experienced in vivo so as to allow meaningful inferences and 
interpretations to be made from studies performed in this valuable system. 
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FIGURE 1.3.  Light micrograph of cultured cortical cells.   
This is a brightfield image of cultured cortical neurons (thin white arrows) and glia (thick white 
arrows) at DIV 14.
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Measure of Cell Death 
Many of the results presented in this thesis present quantification of the neurons that have 
died as a result of an insult.  This quantification is based on a well-established protocol for 
measuring the amount of the cytosolic enzyme, lactate dehydrogenase (LDH), released to the 
extracellular media.  Under normal culture conditions LDH is trapped within the cytosol by the 
intact plasma membrane of healthy neurons and glia.  Upon insult, cells begin to die and the 
integrity of the plasma membrane is compromised.  Eventually, the membrane is degraded 
enough to allow intracellular LDH to escape into the extracellular media in a manner that is 
directly proportional to the number of necrotic or apoptotic cells (Lobner, 2000). 
By sampling the extracellular media we can determine the amount of LDH released by 
kinetic assay in which LDH catalyzes the production of lactic acid from pyruvate using NADH.  
Because NADH absorbs light at ~340 nm, we can measure the rate of its loss (i.e. use in this 
reaction).  We design our experiments with appropriate controls that include an untreated group 
and a group that has been exposed to an insult known to kill 100% of the neurons (500 
micromolar NMDA) or 100% of the neurons and glia (20 micromolar A23187, a calcium 
ionophore).  Once we have the data from the control groups and our experimental groups, we 
subtract the LDH value observed in the untreated group from each of the others (i.e. experimental 
and 100% kill) and then normalize the experimental values to the amount of LDH in the 100% 
kill group.  This technique is briefly illustrated in FIGURE 1.4. 
Since LDH can be released from both neurons and glia, we often pair these results with 
another assay in order to confirm which cell type(s) has/have died.  For this we use the trypan 
blue staining based on the same membrane-integrity principle as the LDH assay.  Only cells that 
have compromised membrane integrity allow trypan blue into the cytosol.  After a short 
incubation with the dye, we wash the excess from the media and visually confirm which cells (i.e. 
cell types: neurons or glia) are stained.  For the experiments in this thesis, all of the 
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neurotoxicants were confirmed to kill only neurons under the conditions presented.  This is not 
surprising given that neurons have long been known to be more sensitive to many insults and 
injuries and glia are often preserved. 
 
 
 
FIGURE 1.4.  LDH assay.   
Upon cell death, the cytosolic enzyme, lactate dehydrogenase (LDH), is able to escape to the 
extracellular media because the plasma membrane is compromised.  Sampling the media allows 
quantification of the amount of enzyme released by exploiting the lower equation and measuring 
the loss of NADH absorbance over time.  Since the amount of LDH released is directly 
proportional to the number of dead cells, this allows the inference of how toxic an insult is. 
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CHAPTER II 
 
 
 
 
 
 
 
 
 
MECHANISMS OF CHLORPYRIFOS AND DIAZINON INDUCED NEUROTOXICITY IN 
CORTICAL CULTURE 
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Abstract 
The main action of organophosphorous insecticides is generally believed to be the 
inhibition of acetylcholinesterase (AChE).  However, these compounds also inhibit many other 
enzymes, any of which may play a role in their toxicity.  We tested the neurotoxic mechanism of 
two organophosphorous insecticides, chlorpyrifos and diazinon, in primary cortical cultures.  
Exposure to the insecticides caused a concentration-dependent toxicity that could not be directly 
attributed to the oxon forms of the compounds, which caused little toxicity but strongly inhibited 
AChE.  Addition of 1 mM acetylcholine or carbachol actually attenuated the toxicity of 
chlorpyrifos and diazinon.  The muscarinic receptor antagonist, atropine, and the nicotinic 
receptor antagonist, mecamylamine, did not attenuate the toxicity of either insecticide.  These 
results strongly suggest that the organophosphorous toxicity observed in this culture system is not 
mediated by buildup of extracellular acetylcholine resulting from inhibition of AChE.  The 
toxicity of chlorpyrifos was attenuated by antagonists of either the NMDA or AMPA/kainate-type 
glutamate receptors, but the cell death was potentiated by the caspase inhibitor ZVAD.  Diazinon 
toxicity was not affected by glutamate receptor antagonists, but was attenuated by ZVAD.  
Chlorpyrifos induced diffuse nuclear staining characteristic of necrosis, while diazinon induced 
chromatin condensation characteristic of apoptosis.  Also, chlorpyrifos exposure increased the 
levels of extracellular glutamate, while diazinon did not.  The results suggest two different 
mechanisms of neurotoxicity of the insecticides, neither one of which involved acetylcholine.  
Chlorpyrifos induced a glutamate-mediated excitotoxicity, while diazinon induced apoptotic 
neuronal death.
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Introduction 
 The organophosphorous insecticides chlorpyrifos and diazinon are potent inhibitors of 
acetylcholinesterase (AChE) activity.  However, organophosphates inhibit many other serine 
hydrolases (Casida and Quistad, 2005).   Exposure to these compounds can induce both acute 
toxicity and long-term neurological deficits (Dahlgren et al., 2004; Lotti and Moretto, 
2005)lottie(Roy et al., 2005; Slotkin et al., 2008).  While they have been banned from residential 
use in the United States, they continue to be widely used throughout the commercial agricultural 
industry.  This widespread use leaves many people at risk for both acute and chronic exposure to 
toxic levels of organophosphorous insecticides.   The focus of research on these compounds has 
been on their ability to inhibit AChE, and how this leads to hyperstimulation of cholinergic 
systems.  This action is clearly important for many of the acute effects of organophosphates, such 
as constriction of the pupils, bronchial constriction, increased sweating, urinary and fecal 
incontinence, convulsions, seizures, inhibition of respiratory drive, and muscle fasciculations.  
The ability of organophosphates to inhibit AChE has led to the hypothesis that they exert their 
neurotoxic effects by increasing acetylcholine concentrations, leading to overstimulation of 
cholinergic receptors and thereby inducing seizure activity and excitotoxic neuronal death 
(Lallement et al., 1998).   However, chlorpyrifos and diazinon can have deleterious effects on the 
nervous system through a variety of mechanisms (Howard et al., 2005; Giordano et al., 2007).  
Chlorpyrifos can increase the expression of NMDA receptors (Gultekin et al., 2007),  while both 
chlorpyrifos and diazinon have been shown to modify expression of neurotrophic factors (Slotkin 
and Seidler, 2007; Slotkin et al., 2007), induce oxidative stress (Kovacic, 2003; Saulsbury et al., 
2009), and impair spatial memory learning in rats (Terry et al., 2003; Timofeeva et al., 2008).  
Interestingly, many of the effects of chlorpyrifos and diazinon have been shown to occur at 
concentrations where they have little effect on AChE (Slotkin and Seidler, 2007; Slotkin et al., 
2007; Timofeeva et al., 2008).   These findings have led to recent interest in the neurotoxic 
mechanisms of chlorpyrifos and diazinon, independent of AChE inhibition.  Our study utilized 
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primary murine cortical cultures to further define the mechanism of chlorpyrifos- and diazinon-
induced neuronal death. 
Materials and Methods 
Materials 
Timed pregnant Swiss Webster mice were obtained from Charles River Laboratories 
(Wilmington, DE).  Fetal bovine serum and horse serum were obtained from Atlanta Biologicals 
(Lawrenceville, GA).  Laminin and glutamine were from Invitrogen (Carlsbad, CA).  
Chlorpyrifos-oxon (97.5% pure) was purchased from ChemService (West Chester, PA). 
Diazinon-oxon (92.7%) was purchased from Accustandard (New Haven, CT). Chlorpyrifos 
(99.2% pure), diazinon (99.0% pure) and all other chemicals were obtained from Sigma (St. 
Louis, MO).  
 
Cortical cell cultures   
Mixed cortical cell cultures were prepared from fetal (15-16 day gestation) mice as 
previously described (Lobner, 2000).  Briefly, dissociated cortical cells were plated on 24 well 
plates coated with poly-D-lysine and laminin in Eagles‟ Minimal Essential Medium (MEM, 
Earle‟s salts, supplied glutamine-free) supplemented with 5% heat-inactivated horse serum, 5% 
fetal bovine serum, 2 mM glutamine and glucose (total 21 mM).  Cultures were maintained in 
humidified 5% CO2  incubators at 370C.  Nearly-pure glia cultures were prepared as described 
above except from postnatal day 1-2 mice in which only glia survive (McCarthy and de Vellis, 
1980; Choi et al., 1987).  Nearly-pure neuronal cultures were prepared as described for mixed 
cultures with cytosine arabinoside (10 μM) added to the cultures 48 hours after plating to inhibit 
glial replication.  Less than 1% of cells in these cultures stain for glial fibrillary acidic protein 
(GFAP) (Dugan et al., 1995). 
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Induction of neuronal death  
Toxicity experiments were performed on cultures 13-15 days in vitro (DIV).  Neuronal 
death was induced by 24-hour exposure to chlorpyrifos, chlorpyrifos-oxon, diazinon or diazinon-
oxon in media the same as in which cells were plated except lacking serum.  
 
Assay of cell death (LDH Release)   
Cell death was assessed in mixed cultures by the measurement of lactate dehydrogenase 
(LDH) released from damaged or destroyed cells to the extracellular fluid 24 hours after the 
beginning of the insult.  Control LDH levels were subtracted from insult LDH values and results 
normalized to 100% neuronal death caused by 500 μM NMDA.  Control experiments have shown 
previously that the efflux of LDH occurring from either necrotic or apoptotic cells is proportional 
to the number of cells damaged or destroyed (Koh and Choi, 1987; Lobner, 2000).   
 
Propidium iodide staining 
Cultures were exposed to the non-vital dye propidium iodide (10 µM) for 30 minutes, 
following 24-hour exposure to the insecticides.  Digital images were taken with a Zeiss LSM 5 
PASCAL confocal microscope at a magnification of 630X. 
 
 
Analysis of extracellular glutamate  
Extracellular glutamate was measured following 6-hour exposure to chlorpyrifos or diazinon.  
Samples of the bathing media from the cell cultures are assayed for glutamate by using 
phenylisothiocyanate (PITC) derivatization, HPLC (Agilent 1100) separation using a Hypersil-
ODS reverse phase column, and ultraviolet detection at a wavelength of 254 nm (Cohen et al., 
1986; Lobner and Choi, 1996).   Bathing media (200 µL) was derivatized with 100 µL of PITC, 
methanol, triethylamine (TEA) and dried under vacuum.   These samples are then reconstituted in 
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solvent consisting of 0.14 M sodium acetate, 0.05% TEA, 6% acetonitrile, brought to pH 6.4 with 
glacial acetic acid.  The above solvent is used as the mobile phase, with the column being washed 
in 60% acetonitrile, 40% water between each sample run.  Media glutamate concentrations are 
calculated by normalizing to glutamate standards.  Glutamate measurements are found to be 
linear over the range 0.1 - 10 μM.  
 
Measurement of acetylcholinesterase activity in vitro. 
Acetylcholinesterase activity in mixed cultures was measured by a modified Ellman assay 
(Ellman et al., 1961).  Briefly, cells were washed into phosphate-buffered saline (PBS) with 0-
100 µM concentrations of chlorpyrifos, chlorpyrifos-oxon, diazinon or diazinon-oxon.  300 µM 
5,5‟-dithio-bis(2-nitrobenzoic acid) (DTNB) was added to all wells at the start of the assay.  
Control and experimental wells were also supplied with 0.42 µM acetylthiocholine iodide 
(ASChI).  Following 1-hour incubation, 50 µL samples of the extracellular media were taken and 
absorbency at 405 nm determined on a plate reader.  AChE activity was normalized to protein 
levels and calculated as percent control after subtraction of background absorbance measured in 
those cultures supplied with only PBS and DTNB. 
 
Statistical analysis. 
Differences between test groups were examined for statistical significance by means of one-way 
ANOVA followed by the Bonferroni t-test, with p<0.05 being considered significant. 
Results 
Concentration dependent toxicity of chlorpyrifos and diazinon  
We first tested chlorpyrifos and diazinon for toxicity in mixed neuronal and glial cortical 
cultures.  Both compounds were toxic, with diazinon causing significant toxicity at a lower 
concentration (30 µM) than chlorpyrifos (100 µM) (FIGURE 2.1 A and C).  However, we found 
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that chlorpyrifos-oxon induced only low-level toxicity (FIGURE 2.1 B), even at a concentration 
of 100 µM, while diazinon-oxon caused no neuronal death (FIGURE 2.1 D).  Therefore, the 
majority of the neuronal death induced by 100 µM chlorpyrifos and 30 µM diazinon cannot be 
caused by the oxon forms of the compounds.  In the experiments that follow, 30 µM diazinon and 
100 µM chlorpyrifos were used because these were concentrations that induce intermediate levels 
of neuronal death.  The toxicity at these concentrations was primarily due to neuronal cell death, 
as they induced minimal cell death when tested on pure glial cultures (30 µM diazinon induced 
3+1 % glial cell death; 100 µM chlorpyrifos induced 2+1% glial cell death; n = 16). 
 
Acetylcholinesterase inhibition by chlorpyrifos, diazinon and their respective oxons 
 We next measured the ability of chlorpyrifos, diazinon and their respective oxons to 
inhibit AChE activity.  Chlorpyrifos and diazinon were capable of substantial AChE inhibition at 
high concentrations (FIGURE 2.2 A and C), while the oxon forms of these compounds proved to 
be more potent and efficacious AChE inhibitors than their precursors (FIGURE 2.2 B and D).  
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FIGURE 2.1.  Organophosphorous pesticides induce toxicity in cortical culture.  
Chlorpyrifos (A), chlorpyrifos-oxon (B), diazinon (C), and diazinon-oxon (D) induce toxicity in 
primary cortical cultures. Bars show % neuronal cell death (mean + SEM, n=8) quantified by 
measuring release of LDH 24 hrs after the beginning of the insult. * indicates significantly 
different from control. 
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FIGURE 2.2.  Organophosphorous pesticides inhibit acetylcholinesterase activity in cortical 
culture.   
Chlorpyrifos (A), chlorpyrifos-oxon (B), diazinon (C) and diazinon-oxon (D) inhibit AChE 
activity in cortical culture.  Bars show % acetylcholinesterase activity (mean + SEM, n=8) 
relative to control cultures after normalization to protein following 1-hour incubation with ASChI 
and DTNB.  * indicates significant difference from control. 
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Toxicity of chlorpyrifos and diazinon is not mediated by increased extracellular acetylcholine 
The next set of experiments was to determine whether the toxicity of these agents was 
due to inhibition of AChE.  We first tested the effects of acetylcholine and its non-hydrolyzable 
analog, carbachol.  Neither of these compounds was toxic, even at a concentration of 1 mM 
(FIGURE 2.3).  If chlorpyrifos or diazinon was toxic by inhibiting AChE, causing acetylcholine 
buildup, the addition of acetylcholine or carbachol would be expected to potentiate their toxicity.  
Instead, acetylcholine and carbachol were protective against chlorpyrifos and diazinon toxicity 
(FIGURE 2.3).  We also tested if acetylcholine receptor antagonists were protective against 
chlorpyrifos and diazinon toxicity.  Neither the muscarinic acetylcholine receptor antagonist, 
atropine, nor the nicotinic acetylcholine receptor antagonist, mecamylamine, were protective 
against chlorpyrifos or diazinon toxicity (FIGURE 2.4). 
  
42 
 
 
 
FIGURE 2.3.  Cholinergic agonists are not toxic and partially protect against chlorpyrifos and 
diazinon. 
Acetylcholine and carbachol are not toxic and partially protect against chlorpyrifos (A) and 
diazinon (B) toxicity.  ACh: 1 mM acetylcholine; Carb: 1 mM carbachol. Bars show % neuronal 
cell death (mean + SEM, n =12-20) quantified by measuring release of LDH, 24 hrs after the 
beginning of the insult. * indicates significantly different from chlorpyrifos or diazinon alone. 
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FIGURE 2.4.  Cholinergic antagonists are not protective against chlorpyrifos and diazinon. 
The muscarinic receptor antagonist atropine and the nicotinic receptor antagonist mecamylamine 
are not protective against chlorpyrifos (A) or diazinon (B) toxicity. Atropine: 1 mM atropine; 
Mecam: 10 µM mecamylamine. Bars show % neuronal cell death (mean + SEM, n = 8-16) 
quantified by measuring release of LDH, 24 hrs after the beginning of the insult.  
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Chlorpyrifos induces excitotoxicity, diazinon induces apoptosis 
 To determine the mechanism of toxicity of chlorpyrifos and diazinon, we first tested the 
protective effects of various pharmacological agents.  Chlorpyrifos toxicity was attenuated by 
NMDA-type glutamate receptor antagonists, the non-competitive antagonist dizocilpine (MK-
801), and the competitive antagonist D-2-amino-5-phosphovaleric acid (APV).  The competitive 
AMPA/kainate-type glutamate receptor antagonist, 6,7-dinitroquinoxaline-2,3-dione (NBQX), 
was also protective.  However, the caspase inhibitor, Z-Val-Ala-Asp-fluoromethylketone 
(ZVAD), actually enhanced chlorpyrifos toxicity (FIGURE 2.5 A).  In contrast, diazinon toxicity 
was not affected by glutamate receptor antagonists, but was attenuated by the caspase inhibitor 
ZVAD (FIGURE 2.5 B).  These results suggest that chlorpyrifos induces an excitotoxic neuronal 
death, while diazinon induces apoptosis.  To test this further, we observed the cells following 
propidium iodide staining.  Propidium iodide binds to DNA of dying cells in which the cell 
membrane has been disrupted.  Following chlorpyrifos exposure there was diffuse nuclear 
staining indicating generalized, random, DNA breakdown,  indicative of necrosis (Lobner et al., 
2003), while following diazinon exposure many of cells showed nuclear condensation and 
fragmentation into discrete spherical or irregular shapes, characteristic of apoptosis (Lobner et al., 
2003)(FIGURE 2.6).   
 The pharmacological studies indicate that chlorpyrifos induces excitotoxic neuronal 
death.  This may be caused either by increased extracellular glutamate or by the cells being more 
sensitive to glutamate toxicity.  We found that chlorpyrifos did increase extracellular glutamate, 
while diazinon did not have this effect (FIGURE 2.7 A).  Extracellular glutamate was assayed 
after a 6 hour insecticide exposure because at that time there was not cell death assessed by LDH 
release.  To determine the source of glutamate, we tested the effects of chlorpyrifos on both pure 
neuronal and pure glial cultures.  Chlorpyrifos increased extracellular glutamate in each type of 
culture (FIGURE 2.7 B & C).  
45 
 
 
FIGURE 2.5.  Glutamate receptor antagonists block chlorpyrifos toxicity; an apoptosis inhibitor 
blocks diazinon toxicity. 
The glutamate receptor antagonists MK-801, APV, and NBQX protect against chlorpyrifos (A) 
but not diazinon (B) toxicity, while the caspase inhibitor ZVAD protects against diazinon but not 
chlorpyrifos toxicity.  MK-801: 10 µM MK-801; APV: 200 µM APV; NBQX: 20 µM NBQX; 
ZVAD: 100 µM ZVAD.  Bars show % neuronal cell death (mean + SEM, n=8-16) quantified by 
measuring release of LDH, 24 hrs after the beginning of the insult. * indicates significantly 
different from chlorpyrifos or diazinon alone. 
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FIGURE 2.6.  Chlorpyrifos causes necrosis; diazinon induces apoptosis. 
Chlorpyrifos induces DNA breakdown characteristic of necrosis (A), while diazinon induces 
DNA fragmentation characteristic of apoptosis (B) as detected by propidium iodide staining.  
Propidium iodide (10 µM) was added for 30 minutes, 24 hours after the beginning of the insult. 
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FIGURE 2.7.  Extracellular glutamate levels following chlorpyrifos and diazinon exposures.  
Chlorpyrifos, but not diazinon, induces increased extracellular glutamate in mixed neuronal and 
glial cultures (A), pure neuronal cultures (B), and pure glial cultures (C). CPF: 100 µM 
chlorpyrifos; DZN: 30 µM diazinon. Bars indicate glutamate concentrations (μM) in media (mean 
+ SEM, n=8-16) quantified by HPLC determination.  * indicates significantly different from 
control.   
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Discussion 
Chlorpyrifos and diazinon both induced neuronal death, but through very different 
mechanisms.  Chlorpyrifos induced a clear excitotoxic neuronal death.  The fact that both the 
NMDA receptor antagonists MK-801 and APV, and the AMPA/kainate antagonist NBQX were 
protective suggests that both types of receptors were involved in the neuronal death.  This was not 
unexpected.  While the NMDA receptor/channel is most often implicated in excitotoxic neuronal 
death because of its high calcium permeability (Choi, 1992), the cell membrane must be 
depolarized to remove the magnesium block of the NMDA receptor/channel before the calcium 
influx can occur.  Opening of the sodium permeable AMPA/kainate receptor channels can 
provide this required depolarization.  Two different NMDA antagonists were used because non-
competitive antagonists, including MK-801, have been found to directly inhibit AChE, while also 
preventing its inactivation by diisopropylfluorophosphate (Galli and Mori, 1996).  The 
competitive antagonist, APV, is not known to have these effects.  Chlorpyrifos has also been 
shown to induce excitotoxicity in vivo.  However, this action has been attributed to its inhibition 
of AChE leading to increased extracellular acetylcholine, which has been proposed to induce 
seizure activity (Lallement et al., 1998).  This is clearly not the mechanism involved in our 
studies.  The current studies indicate an alternative, or complementary, mechanism for 
chlorpyrifos toxicity.  That is, chlorpyrifos increases extracellular glutamate through a non-
acetylcholine mechanism.  The mechanism by which chlorpyrifos increased extracellular 
glutamate was not determined.  It may involve either increased glutamate release, decreased 
glutamate uptake, or both.   
 A recent study found that chlorpyrifos induced death of oligodendrocyte progenitor cells 
in culture (Saulsbury et al., 2009).  The result is consistent with our study in that atropine and 
mecamylamine were also found to not be protective.  The mechanism of toxicity was determined 
to be induction of oxidative stress.  The difference is that in our culture system we studied 
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neuronal cell death where excitotoxicity is more likely to play a prominent role, although it is 
quite possible that oxidative stress also is involved. 
 The toxic effects of diazinon are very different than those of chlorpyrifos, although its 
effects are also not mediated by inhibition of AChE.  Diazinon-induced neuronal death did not 
involve excitotoxicity, but had characteristics of apoptosis.  The toxicity was blocked by the non-
selective caspase inhibitor ZVAD, and the propidium iodide staining indicated condensed and 
fragmented DNA.  In contrast, chlorpyrifos induced an excitotoxic and necrotic cell death.  This 
was confirmed by the propidium iodide staining, which showed diffuse nuclear staining 
consistent with necrosis.   While excitotoxicity can induce apoptosis in some systems, in the 
culture system used for these studies it has been shown that excitotoxicity causes necrosis (Gwag 
et al., 1997).  Chlorpyrifos has been shown to induce apoptosis in human T cells (Li et al., 2009) 
and placental cells (Saulsbury et al., 2008), but these cells are not electrically excitable and would 
not be vulnerable to excitotoxicity.  Interestingly, chlorpyrifos has also been shown to induce 
apoptosis in rat cortical cultures (Caughlan et al., 2004).  The difference between that study, and 
our current study, is likely that in the previous study chlorpyrifos exposure was initiated in 
cultures DIV 5-7, while in our studies exposure was begun on cultures DIV 13-15.  Sensitivity to 
glutamate-induced excitotoxicity is known to increase with the length of time in culture prior to 
glutamate insult (Choi et al., 1987). 
A recent study tested concentrations of chlorpyrifos and diazinon that caused minimal 
AChE inhibition, too low to cause cholinergic hyperstimulation, for their ability to induce 
changes in gene transcription in rats (Slotkin and Seidler, 2007).  Using microarray technology 
they observed large numbers of changes.  There were a number of results of interest for the 
current studies.   First, both chlorpyrifos and diazinon increased expression of caspases, 
suggesting possible induction of apoptosis.  Interestingly, the authors indicate “DZN had more 
widespread effects on bax, bmf, casp1 and casp4, implying that DZN may produce greater 
apoptosis than CPF.”  Second, chlorpyrifos caused significantly greater increases in expression of 
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NMDA receptor subunits, particularly of the gene encoding for the NR2B subunit, than diazinon.  
The NR2B subunit is believed to play a particularly prominent role in excitotoxicity due to the 
increased calcium permeability of channels containing the NR2B subunit (Liu et al., 2007).  This 
finding is consistent with our results that chlorpyrifos induces excitotoxicity.  We found evidence 
for actions of chlorpyrifos on extracellular glutamate, not on postsynaptic receptors.  However, 
this does not exclude a concomitant effect at the level of glutamate receptors.  Unfortunately, 
expression of genes involved in glutamate release and uptake were not studied in the microarray 
paper. 
 The finding that high concentrations of acetylcholine or carbachol were protective against 
both chlorpyrifos and diazinon toxicity was somewhat surprising in that the mechanisms by 
which the insecticides induce cell death are different.  However, acetylcholine receptor activation, 
of either the nicotinic or muscarinic receptor, has been shown previously to be protective against 
both excitotoxicity (Felipo et al., 1998; Dajas-Bailador et al., 2000) and apoptosis (Yan et al., 
1995; Fucile et al., 2004).   In addition to examining the effects of cholinergic agonists and 
antagonists, we also measured the capabilities of each compound to inhibit AChE in cortical 
culture.  Chlorpyrifos and diazinon can be converted to their oxon forms which are more effective 
at inhibiting AChE (Capodicasa et al., 1991; Nigg and Knaak, 2000) and these oxons may 
therefore be responsible for their toxicity.  We included these oxon forms in the studies in order 
to analyze the correlation between neurotoxicity and AChE inhibition.  Interestingly, and in 
accordance with the lack of toxicity of acetylcholine and carbachol, the ability of each compound 
did not correlate well with the toxicity results.  That is, chlorpyrifos-oxon and diazinon-oxon 
were the least toxic despite being the most potent and efficacious inhibitors of AChE.  Taken 
together, the data strongly suggests that the toxicity of chlorpyrifos and diazinon, in this system, 
is not mediated by inhibition of AChE and increased extracellular acetylcholine. 
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CHAPTER III 
 
 
 
 
 
 
 
 
 
EFFECTS OF CHELATORS ON MERCURY, IRON, AND LEAD NEUROTOXICITY IN 
CORTICAL CULTURE 
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Abstract 
Chelation therapy for the treatment of acute, high dose exposure to heavy metals is 
accepted medical practice.  However, a much wider use of metal chelators is by alternative health 
practitioners for so called “chelation therapy”.  Given this widespread and largely unregulated use 
of metal chelators it is important to understand the actions of these compounds.  We tested the 
effects of four commonly used metal chelators, calcium disodium ethylenediaminetetraacetate 
(CaNa2EDTA), D-penicillamine (DPA), 2,3 dimercaptopropane-1-sulfonate (DMPS), and 
dimercaptosuccinic acid (DMSA) for their effects on heavy metal neurotoxicity in primary 
cortical cultures.  We studied the toxicity of three forms of mercury, inorganic mercury (HgCl2), 
methyl mercury (MeHg), and ethyl mercury (thimerosal), as well as lead (PbCl2) and iron (Fe-
citrate).  DPA had the worst profile of effects, providing no protection while potentiating HgCl2, 
thimerosal, and Fe-citrate toxicity.  DMPS and DMSA both attenuated HgCl2 toxicity and 
potentiated thimerosal and Fe toxicity, while DMPS also potentiated PbCl2 toxicity.  
CaNa2EDTA attenuated HgCl2 toxicity, but caused a severe potentiation of Fe-citrate toxicity.  
The ability of these chelators to attenuate the toxicity of various metals is quite restricted, and 
potentiation of toxicity is a serious concern.  Specifically, protection is provided only against 
inorganic mercury, while it is lacking against the common form of mercury found in food, MeHg, 
and the form found in vaccines, thimerosal.  The potentiation of Fe-citrate toxicity is of concern 
because of iron‟s role in oxidative stress in the body.  Potentiation of iron toxicity could have 
serious health consequences when using chelation therapy.  
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Introduction 
Environmental and occupational exposure to heavy metals such as mercury and lead are 
of significant concern world-wide.  Such metals are known to target the mammalian central 
nervous system and have been implicated in the development of neurodegenerative diseases such 
as Alzheimer‟s and Parkinson‟s disease (Praline et al., 2007).   Childhood exposure to mercury or 
lead is of specific concern given the deleterious effects that each of these metals impose on the 
developing nervous system (Ellis and Kane, 2000). 
Mercury is found in multiple forms in the environment.  Elemental mercury can be 
released from dental amalgam restorations (Patterson et al., 1985) and the mercury vapor can be 
readily absorbed (Hursh et al., 1976).  The elemental mercury can then be converted into 
inorganic mercury in the body which can accumulate in the brain (Bjorkman et al., 2007).  
Methyl mercury accumulates in fish inhabiting mercury-contaminated lakes and oceans and is of 
specific concern because it is readily absorbed from the GI tract and is actively transported across 
the blood-brain barrier (Kerper et al., 1992; Kostial et al., 2005).  While MeHg is thought to be 
cleared from the brain, it is possible that over multiple exposures significant amounts of MeHg 
can become demethylated to inorganic mercury and accumulate in brain tissue.  Monkeys that 
have undergone MeHg exposure were found to have little organic mercury in their brains 6 
months later, but had higher than normal inorganic mercury (Burbacher et al., 2005).  Mercury 
has been shown to have a substantially longer half-life in the brain than in the blood stream (Rice, 
1989).  Thimerosal, an antiseptic containing ethyl mercury, continues to be used as a preservative 
of vaccines distributed and administered worldwide with its use in the US only recently 
decreasing (Geier et al., 2007).  Direct intramuscular injection of this compound provides rapid 
access to the blood stream and thereby privileged access to its target organs, possibly including 
nervous tissue. 
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Lead exposure is also widespread. Commercial use of lead is quite broad, with various 
lead compounds serving as components in many common products such as lead-based paints 
found in older homes, as well as being used in the manufacture of batteries (Shukla and Singhal, 
1984; Jarup, 2003). 
The concerns with iron are somewhat different.  While environmental exposure to iron 
does occur, for example, from drinking water, iron pipes, and cookware, the main concern is the 
inappropriate release of iron in the body.  Iron can be released from the breakdown of 
hemoglobin following aneurysm or blood disease.  The free iron is dangerous because of its 
ability to generate oxygen free radicals by catalyzing the Fenton reaction (Yamazaki and Piette, 
1990). 
A controversial use of metal chelators has been by alternative health practitioners for the 
treatment of chronic health conditions.  The basic idea is that chronic high levels of heavy metals 
are responsible for health problems such as heart disease, Alzheimer‟s disease, and autism, and 
that these diseases can be treated by chelation therapy to remove the heavy metals from the body.  
Statistics on how often such procedures are performed, what they are used to treat, and whether 
they are effective, or harmful, are limited.  A published study (Barnes et al., 2008) estimated that 
in the year 2002, 66,000 people in the United States underwent chelation therapy.  The number is 
likely to be increasing.  Small scale clinical trials have been performed using chelation therapy 
with EDTA for the treatment of atherosclerotic vascular disease, none of which has showed any 
benefit (Guldager et al., 1993; van Rij et al., 1994; Knudtson et al., 2002).  The National Institutes 
of Health have recently initiated a major clinical trial testing EDTA in people with coronary 
artery disease, the results from this trial should be available in 2012 (website: 
http://www.nccam.nih.gov/chelation). 
At present, the primary clinical treatment of acute heavy metal poisoning is by 
administration of metal chelators.  Chelators such as calcium disodium 
ethylenediaminetetraacetate (CaNa2EDTA), D-penicillamine (DPA), 2,3 dimercaptopropane-1-
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sulfonate (DMPS), and dimercaptosuccinic acid (DMSA) have been designed to effectively 
mobilize and remove toxic metal molecules while limiting the disruption of homeostatic levels of 
essential metals such as zinc.  Chelators have been shown to have varying efficacies depending 
on the metal to which the patient was exposed (Andersen, 2004).  The purpose of the present 
study is to characterize the effects of each chelator on the cytotoxic effects of HgCl2, MeHg, 
Thimerosal, PbCl2, and Fe-citrate.  To study these interactions, we exposed murine primary 
cortical cultures to toxic concentrations of each metal of interest both with and without the 
chelators present. 
Materials and Methods 
Materials 
Timed pregnant Swiss Webster mice were obtained from Charles River Laboratories 
(Wilmington, DE).  Serum was from Atlanta Biologicals (Atlanta, GA).  All chemicals were 
obtained from Sigma (St. Louis, MO). 
 
Cortical cell cultures 
Mixed cortical cell cultures containing both neuronal and glial cells were prepared from 
fetal (15-16 day gestation) mice as previously described (Rose and Ransom, 1997; Lobner, 2000).  
Timed pregnant mice were anesthetized with isoflurane and euthanized by cervical dislocation. 
Dissociated cortical cells were plated on 24 well plates coated with poly-D-lysine and laminin in 
Eagles‟ Minimal Essential Medium (MEM, Earle‟s salts, supplied glutamine-free) supplemented 
with 5% heat-inactivated horse serum, 5% fetal bovine serum, 2mM glutamine and glucose (total 
21 mM).  Cultures were plated at approximately 8 hemispheres per plate.  Glial cultures were 
prepared identical to mixed cultures except cortical cells were obtained from postnatal day 1-3 
mice (McCarthy and deVellis, 1980; Choi et al., 1987).  The postnatal mice were anesthetized 
with isoflurane and euthanized by decapitation.  Glial cultures were plated at approximately 3 
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hemispheres per plate.  Cultures were maintained in humidified 5% CO2  incubators at 370C.  
Mice were handled in accordance with a protocol approved by our institutional animal care 
committee and in compliance with the Public Health Service Policy on Humane Care and Use of 
Laboratory Animals.   
 
Induction of neuronal death   
All experiments were performed on cultures 13-15 days in vitro (DIV), at this time there 
are approximately 150,000 neurons/well (145,900 + 5800; n = 4; data from 4 plates from 4 
different dissections).   Metals and/or chelators were added to the cultures in media identical to 
plating media except lacking serum for 24 hours, at the end of which time a sample of the media 
was taken to perform the LDH release assay to determine the level of cell death. 
 
Assay of cell death (LDH Release)   
Cell death was assessed in mixed or pure glial cultures by the measurement of lactate 
dehydrogenase (LDH), released from damaged or destroyed cells, in the extracellular fluid 24 
hours after the beginning of the insult.  Blank LDH levels were subtracted from insult LDH 
values, and results normalized to 100% neuronal death caused by 500 µM NMDA in mixed 
cultures and 100% glial death caused by 20 µM A23187 in glial cultures.  Approximately 50% 
(51 + 2%, n= 12) of the LDH present in mixed cultures is present in the neurons.  Control 
experiments have shown previously that the efflux of LDH occurring from either necrotic or 
apoptotic cells is proportional to the number of cells damaged or destroyed (Koh and Choi, 1987; 
Gwag et al., 1995; Lobner 2000).   
 
Statistical analysis 
 Differences between test groups were examined for statistical significance by means of 
one-way ANOVA followed by the Bonferroni t-test, with p<0.05 being considered significant. 
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Results 
Concentration-dependent toxicity of HgCl2, MeHg, thimerosal, PbCl2, and Fe-citrate. 
 Figure 3.1 A-E demonstrates the concentration-dependent cytotoxicity with 24-hour 
exposure to increasing concentrations of each of HgCl2, MeHg, thimerosal, PbCl2, and Fe-
citrate.  Cell death was assayed in each case through measuring release of the cytosolic enzyme 
lactate dehydrogenase.   HgCl2 had the most notable effects, especially at 5 µM concentrations, 
while causing approximately 40% cell death at a concentration of 1µM.  MeHg and Thimerosal 
produced similar toxicity profiles, both causing approximately 40% neuronal death at 5µM.   Fe-
citrate required approximately 30 µM to produce 40% neuronal death.  We chose these 
concentrations of each compound for the following experiments to produce an intermediate level 
of cell death.  This allowed for the observation of both increased and decreased toxicity caused by 
the chelators tested.   PbCl2 produced only 25% cell death at a concentration of 100 µM.  We 
decided that this lower toxicity at 100µM would be sufficient to reveal any protection or 
potentiation brought on by presence of a chelator and did not use a higher concentration in order 
to maintain physiological relevance. 
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FIGURE 3.1.  Toxicity of heavy metals in cortical culture. 
Toxicity of (A) inorganic mercury (HgCl2), (B) methyl mercury (MeHg), (C) ethyl mercury 
(thimerosal), (D) lead (PbCl2), and (E) iron (Fe-citrate) in mixed cortical cultures.  Bars show % 
cell death (mean + SEM, n = 16-24) quantified by measuring release of LDH, 24 hrs after the 
beginning of the insult. * indicates significant difference from control. 
 
Metal-induced cell death is neuron-specific. 
 The experiments in Figure 1 were performed using mixed neuronal and glial cultures.  To 
confirm which cells each metal was targeting, we exposed glial cultures  to HgCl2 (1 µM), MeHg 
(5 µM), thimerosal (5 µM), PbCl2 (100 µM) or Fe-citrate (30 µM).  Each of the compounds 
induced less than 5% glial death (HgCl2, 0.4 + .2; MeHg, 3.5 + .7;  thimerosal, 4.0 + .4; PbCl2, 
1.2 + .3; Fe-citrate, 3.5 + 1.7; n = 8).  Therefore, the death observed in mixed cultures is likely 
primarily neuronal death. 
  
59 
CaNa2EDTA, DPA, DMPS and DMSA alone are not neurotoxic. 
 The inherent toxicity of each chelator was tested.  CaNa2EDTA, DPA, DMPS or DMSA 
alone, at a concentration of 100 µM, caused less than 5% cell death in mixed cortical cultures 
(EDTA, 2.6 + 1.1; DPA, 2.4 + 2.3; DMPS, 4.8 + 2.1; DMSA, 3.7 + 1.3; n = 8).   
 
Effects of chelators on metal toxicity.  
 Co-application of 100µM CaNa2EDTA attenuated HgCl2 toxicity, but not MeHg, 
thimerosal or lead toxicity. The CaNa2EDTA also caused a dramatic potentiation of Fe-citrate 
toxicity.  The death caused by the combination of CaNa2EDTA and Fe-citrate is indicated to be 
greater than 100%.  This number is an artifact of the calculation, in our studies 100% neuronal 
death is defined as complete neuronal death caused by a high concentration of NMDA.  The fact 
that in this case there is more LDH release than that occurring during NMDA exposure indicates 
that the combination of CaNa2EDTA and Fe-citrate causes not only death of 100% of the 
neurons, but also death of some of the glial cells present in these cultures (FIGURE 3.2 A).  If the 
calculation were based on total LDH release possible (neurons and glia) the values presented for 
all of the other studies in which the death was purely neuronal would be misleading.  Addition of 
100µM DPA failed to provide protection against toxicity induced by any of the metals.  
Furthermore, it enhanced the toxicity of HgCl2, thimerosal, and Fe-citrate (FIGURE 3.2 B).  
Addition of 100µM DMPS significantly attenuated HgCl2-induced neuronal death, but it 
potentiated thimerosal, Fe-citrate, and PbCl2 toxicity (FIGURE 3.2 C).  Similar to DMPS, 
DMSA also attenuated HgCl2 toxicity, while potentiating thimerosal and Fe-citrate toxicity, but it 
had no effect on MeHg or PbCl2 toxicity (FIGURE 3.2 D). 
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FIGURE 3.2.  Effects of chelators on heavy metal toxicity. 
Effects of (A) CaNa2EDTA, (B) DPA, (C) DMPS, and (D) DMSA on metal toxicity in mixed 
cortical cultures. HgCl2 (1 µM), MeHg (5 µM), Thimerosal (5 µM), PbCl2 (100 µM), Fe-citrate 
(30 µM), CaNa2EDTA (100 µM), DPA (100 µM), DMPS (100 µM), DMSA (100 µM).  All 
compounds were present for 24 hours.  Bars show % cell death (mean + SEM, n = 8-16) 
quantified by measuring release of LDH, 24 hrs after the beginning of the insult.  Open bar 
represents the metal without chelator.  * indicates significant difference from control injury 
(metal without chelator present). 
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Discussion 
 An important question concerning the use of metal chelators is whether they increase or 
decrease levels of heavy metals in the brain.  British Anti-Lewisite (BAL), the first chelator used 
clinically for mercury intoxication, was far from ideal as it was found to mobilize and relocate 
mercury and lead to the brain increasing their neurotoxic effects (Andersen, 2004).  Derivatives 
of BAL, DMPS and DMSA, have come into use because they are significantly less toxic than 
BAL.  Their effects on brain metal levels are more complex.  Aposhian et al. 1996 exposed rats to 
inorganic lead or inorganic mercury for 86 or 41 days, respectively, prior to treatment with 
DMPS (Aposhian et al., 1996).  In their study, DMPS reduced kidney levels of mercury while 
causing no change in brain levels of mercury or lead.  DMSA, which is approved in the US for 
the treatment of lead-poisoned children has been shown to decrease brain lead (Cory-Slechta, 
1988) and methyl mercury (Aaseth and Frieheim, 1978).  However, DMSA, as well as DMPS, 
have been shown to increase the uptake of inorganic mercury into motor neurons (Ewan and 
Pamphlett, 1996) and both DMPS and DMSA have been found to be ineffective at eliminating 
mercury  from the body (Eyer et al., 2006).  Whether chelator metal complexes enter the brain is 
not clear.  We have found that the ability of the chelators to attenuate neurotoxicity of metals is 
very limited.   While CaNa2EDTA, DMPS, and DMSA each attenuated the toxicity of HgCl2, 
they did not attenuate the toxicity of the organic forms of mercury, and potentiated the toxicity of 
at least one metal.   
 Of the forms of mercury tested, HgCl2 was the most toxic, particularly at a concentration 
of 5 µM.   This may be surprising in that MeHg is generally believed to the most toxic form of 
mercury.  However, the high toxicity of MeHg is due to its ability to be readily absorbed in the 
gastrointestinal tract and to cross the blood brain barrier (Sasser et al., 1978; Burbacher et al., 
2005).  Neither of these events is modeled in the cell culture system used in these studies. 
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 The most commonly used metal chelator for chronic disease is EDTA, either simply as 
EDTA, or as CaNa2EDTA.  The problem with using EDTA, not chelated with calcium, is that it 
can lead to hypocalcemia and potentially death (Brown et al., 2006).  However, treatment with 
CaNa2EDTA has been shown to cause a temporary increase in brain lead or mercury levels 
following its administration (Berlin et al., 1965; Cory-Slechta et al., 1987).  
Chelators, while thought to directly limit metal toxicity through binding (and thereby 
blocking harmful reactivity), have been shown to have varying effects when accompanied by 
their target metals.  Binding of iron by EDTA actually increases the ability of iron to induce free 
radicals because it makes iron more soluble in physiological solutions and increases the ability of 
iron to promote the formation of hydroxyl radicals via the Fenton reaction (Smith et al., 1990). 
Therefore, binding of metals to chelators may actually increase their ability to induce cell death.  
This is, in fact, what we observed with each of the chelators tested. 
  Of the chelators tested, DMSA appears to have the best profile of effects.  It 
attenuates HgCl2 toxicity, while causing only moderate enhancement of thimerosal and Fe-citrate 
toxicity.  DPA had the worst profile of effects, providing no protection, and enhancing HgCl2, 
thimerosal, and Fe-citrate toxicity.  The other chelators that attenuated HgCl2 toxicity, DMPS and 
CaNa2EDTA, each have other injury enhancing actions.  DMPS enhances PbCl2 toxicity, and 
CaNa2EDTA causes a severe potentiation of Fe-citrate toxicity.  The fact that all of the chelators 
cause potentiation of some form of metal toxicity is of concern regarding their long-term, and 
widespread, use for chelation therapy.  It has been shown previously that EDTA can increase iron 
induced free radical formation, but the fact that each of the chelators tested was found to increase 
iron toxicity is worrying.  Considering the variety of results on chelator effects on brain levels of 
heavy metals, it is important to gain further understanding of how chelator-binding alters the 
toxicity of these metals.   
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CHAPTER IV 
 
 
 
 
 
 
 
 
 
GLUTATHIONE-MEDIATED NEUROPROTECTION AGAINST METHYLMERCURY IN 
CORTICAL CULTURE IS DEPENDENT ON MRP1 
 
 
64 
Abstract 
Methylmercury (MeHg) exposure poses significant neurotoxic threat to humans 
worldwide.  The present study investigated the mechanisms of glutathione-mediated attenuation 
of MeHg neurotoxicity in primary cortical culture.  MeHg caused depletion of mono- and 
disulfide glutathione in neuronal, glial and mixed cultures.  Supplementation with exogenous 
glutathione, specifically glutathione monoethyl ester (GSHME) protected against the MeHg 
induced neuronal death.  MeHg caused increased reactive oxygen species (ROS) formation 
measured by dichlorodihydrofluorescein (DCF) fluorescence with an early increase at 30 minutes 
and a late increase at 6 hours.  This oxidative stress was prevented by the presence of either 
GSHME or the free radical scavenger, trolox.  While trolox was capable of quenching the ROS, it 
showed no neuroprotection.  Exposure to MeHg at subtoxic concentrations caused an increase in 
system xc
-
 mediated 14C-cystine uptake that was blocked by the protein synthesis inhibitor, 
cycloheximide (CHX).  Interestingly, blockade of the early ROS burst prevented the functional 
upregulation of system xc
-
 .  Inhibition of multidrug resistance protein-1 (MRP1) potentiated 
MeHg neurotoxicity and increased cellular MeHg.  Taken together, these data suggest glutathione 
offers neuroprotection against MeHg toxicity in a manner dependent on MRP1-mediated efflux. 
Introduction 
Methylmercury (MeHg) is an ubiquitous and potent neurotoxicant posing significant 
threat to humans primarily through dietary exposure.  Exposure to MeHg has been implicated as a 
factor in the development of neurodegenerative diseases such as Alzheimer‟s Disease, 
Parkinson‟s Disease, and Amyotrophic Lateral Sclerosis (ALS)(Hock et al., 1998; Monnet-
Tschudi et al., 2006; Praline et al., 2007).  Humans are primarily exposed to MeHg through 
consumption of contaminated fish and shellfish.  MeHg is formed by bacterial methylation of 
inorganic mercury in aquatic sediments (Clarkson, 1997).   MeHg then travels up the food chain 
and accumulates in fish and shellfish, and is subsequently consumed by humans (Mahaffey et al., 
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2004).  There is clear evidence for neurological deficits following exposure to high levels of 
mercury.  For example, a large release of MeHg into Minamata Bay in Japan led to toxic levels of 
exposure and severe injury to the local population, including neurological dysfunctions (Harada, 
1995; Tsuda et al., 2009).  In a separate incident, methylmercury-contaminated seed grain was 
sent to a population in Iraq with its consumption leading to severe neurological injuries (Myers et 
al., 2000).  Acute exposure to high levels of mercury is known to target cerebellar granular 
neurons, however, cortical damage from environmental exposure to mercury is likelier to underly 
its implicated role in the etiology of the aforementioned neurodegenerative diseases.   While 
humans are exposed to other forms of mercury, such as elemental mercury found in dental 
amalgam restorations, or ethylmercury found in the commercial preservative, thimerosal, MeHg 
is of specific concern because it is easily absorbed in the gastrointestinal tract, and readily 
traverses the blood-brain barrier (BBB)(Bridges and Zalups, 2005, 2010). 
Proposed mechanisms for MeHg neurotoxicity are primarily focused on three 
possibilities: disruption of intracellular calcium and zinc ion homeostasis, likely involving 
mitochondrial deficits (Atchison and Hare, 1994; Kawanai et al., 2009), redox imbalance by 
increased production of reactive oxygen species and/or by decreasing endogenous cellular 
antioxidant defenses (Ali et al., 1992; Aschner, 2000), and direct interactions with free protein 
sulfhydryl groups (Rooney, 2007).  The present study is aimed at determining the effects of 
MeHg on the glutathione (GSH) cycling system and oxidative stress. 
Astrocytes are thought to be responsible for de novo synthesis of glutathione from 
glutamate, glycine and the rate limiting substrate, cysteine, which is brought into the astrocytes 
primarily in its oxidized form, cystine.  Glutathione can be utilized by the cell to reduce reactive 
oxygen species, such as superoxide, produced as a byproduct of mitochondrial energy production; 
this superoxide rapidly reacts to form hydrogen peroxide which is then reduced by glutathione to 
form glutathione-disulfide (GSSG) and water in a reaction catalyzed by glutathione peroxidase.  
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Glutathione may also be utilized as a xenobiotic detoxicant as has been well characterized 
involving chemotherapeutics in cancer treatment.  That is, glutathione can be directly conjugated 
to exogenous substrates via a disulfide bond with the free sulfhydryl groups; these reactions are 
directed by a class of enzymes known as glutathione-S-transferases (GSTs)(Dringen, 2000; 
Dringen and Hirrlinger, 2003).  GSH, GSSG and the glutathione-conjugates are then exported 
from the cell in a glutathione-dependent manner via multi-drug resistance proteins (MRP), 
specifically MRP1 in the CNS (Hirrlinger and Dringen, 2005; Minich et al., 2006).  These 
glutathione molecules can then be broken down in the extracellular space by glutathione 
reductase, amino-peptidase N, or gamma-glutamyl transpeptidase.  This metabolism produces the 
substrate cysteine, which can be taken up and utilized by neurons to produce their own 
glutathione.  In this way, neurons are dependent on astrocytes to supply glutathione (Dringen et 
al., 1999).  Since glutathione serves a dual role as both an antioxidant and detoxicant, and both of 
these roles may offer independent protective mechanisms against MeHg, the present study 
examines the impact of MeHg on these aspects of glutathione action. 
 
Materials and Methods 
Materials.  Timed pregnant Swiss Webster mice were obtained from Charles River Laboratories 
(Wilmington, DE, USA).  Serum was from Atlanta Biologicals (Atlanta, GA, USA).  NADPH 
was from Applichem (Darmstadt, Germany).  Radiolabeled 
14
C-Cystine was purchased from 
PerkinElmer (Boston, MA, USA).  S-(4)-carboxyphenylglycine (CPG) and MK571 were obtained 
from Tocris Bioscience (Ellisville, MO, USA).  DCF was from Molecular Probes (Eugene, OR, 
USA).  All other chemicals were from Sigma (St. Louis, MO, USA)  
Cortical Cell Cultures. Mixed cortical cell cultures containing glial and neuronal cells were 
prepared from fetal (15-16 day gestation) mice as previously described (Lobner, 2000).  
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Dissociated cortical cells were plated on 24-well plates (2.0 cm
2
 surface area per well) coated 
with poly-D-lysine and laminin in Eagles‟ Minimal Essential Medium (MEM, Earle‟s salts, 
supplied glutamine-free) supplemented with 5% (v/v) heat-inactivated horse serum, 5% (v/v) fetal 
bovine serum, 2 mM glutamine and D-glucose (total 21 mM).  Neuronal cultures were prepared 
exactly as above with the addition of 10 µM cytosine aribinocide 48 hours after plating to inhibit 
glial replication (Dugan et al., 1995; Rush et al., 2010).  Cultures were plated at approximately 8 
hemispheres per plate in a volume of 0.5 mL per well.  Glial cultures were prepared as described 
for mixed cultures from cortical tissue taken from post-natal day 1-3 mice and plated at 
approximately 3 hemispheres per plate (Choi et al., 1987; Schwartz and Wilson, 1992; Rush et 
al., 2009).  Cultures were maintained in humidified 5% CO2 incubators at 37
0
C.  Mice were 
handled in accordance with a protocol approved by our institutional animal care committee and in 
compliance with the Public Health Service Policy on Humane Care and Use of Laboratory 
Animals.  All experiments were performed in media identical to growth media except lacking 
serum (MS) at a volume of 0.4 mL per well.  All experiments were performed on mixed cortical 
cultures, except where noted. 
Assay of neuronal death.  Cell death was assessed in cultures by the measurement of lactate 
dehydrogenase (LDH), released from damaged or destroyed cells, in the extracellular fluid 24 
hours after the beginning of the insult.  Insults were performed by washing cultures into MS or 
MS containing the indicated chemicals and incubating overnight.  Control LDH levels were 
subtracted from insult LDH values, and results normalized to 100% neuronal death caused by 500 
M NMDA.  Control experiments have shown previously that the efflux of LDH occurring from 
either necrotic or apoptotic cells is proportional to the number of cells damaged or destroyed 
(Koh and Choi, 1987; Lobner 2000).  Trypan blue staining indicated that the cell death observed 
was neuron selective.  Cell-free experiments were performed to exclude the possibility of direct 
inhibition of LDH by the pharmacological agents used. 
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Glutathione Assay.  Total cellular glutathione and media glutathione were assayed using a 
modified enzymatic method (Baker et al., 1990; Lobner et al., 2003).  Cultures were washed into 
MS with or without MeHg (5 μM) and incubated for 6 hours.  Media samples of 25 μl were taken 
after the drug application period and assayed as aliquots of supernatant below.  Cultures were 
washed with cold (4 °C) HEPES buffered saline solution, dissolved in 200 µl of 1% sulfosalicylic 
acid, and centrifuged.  A 25 µl aliquot of the supernatant was combined with 150 µl of 0.1 M 
phosphate/5 mM EDTA buffer, 10 µl of 20 mM dithiobis-2-nitrobenzoic acid, 100 µl of 5 mM 
NADPH, and 0.2 U of glutathione reductase. Total glutathione was determined by kinetic 
analysis of absorbance changes at 402 nm for 1.5 min, with concentrations determined by 
comparison to a standard curve. GSSG was measured as above except samples were treated with 
2-vinylpyridine and triethanolamine for 1 hour prior to beginning the reaction.  Cell-free 
experiments were performed to exclude the possibility of assay inhibition by the experimental 
reagents used.  Due to inter-plate culture variance in absolute glutathione measures data in Table 
1 are reported as percent respective intra-plate control glutathione measures.  Untreated control 
values across all culture types were typically in the following ranges (represented as mean 
nmol/well): 1.99-3.33 cellular GSH, 0.24-0.50 media GSH, 0.14-0.74 cellular GSSG, 0.060-0.16 
media GSSG. 
Assay for oxidative stress.  Oxidative stress was measured with 5-(and -6)-2‟7‟-
dichlorodihydrofluorescein diacetate (DCF) using a fluorescent plate reader following a 
modification of a previous method (Wang and Joseph, 1999; Lobner et al., 2007).  Cultures were 
washed into MS and subsequently exposed to treatments by adding drug for the exposure times 
indicated.   10 μM DCF is added to the cultures 30 minutes prior to data acquisition.  
Fluorescence is read using a Fluoroskan Ascent plate reader (Thermo LabSystems) with 
excitation and emission filters set to 485 nm and 538 nm,respectively.  Background fluorescence 
(no DCF added) was subtracted and the results normalized to control conditions. 
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14
C-Cystine Uptake.  Radiolabeled cystine uptake was performed as previously described with 
modifications.  Cultures were exposed to MS containing the indicated drug treatments for 24 
hours, or for 1 hour followed by 23 hours in drug-free MS.  24 hours after the start of the 
experiment, cultures were washed into HEPES buffered saline solution and immediately exposed 
to 
14
C-cystine (0.025 μCi/mL, 200 nM total cystine) for 20 minutes.  Following 14C-cystine 
exposure, cultures were washed with ice cold HEPES buffered saline solution and dissolved in 
250 μl warm sodium dodecyl sulfate (0.1%).  An aliquot (200 μl) was removed and added to 
scintillation fluid for counting.  Values were normalized to 
14
C-cystine uptake in untreated 
controls of the same experimental plate. 
Determination of MeHg content in cells by ICP-MS.  Following 6 hour exposure to MS with or 
without the indicated treatments, cultures were washed 3x with cold MS and then dissolved in 
100 μl 1% sulfosalicylic acid. Samples were combined with 900 μl 5% HNO3 containing 500 ppb 
Au and digested at 70°C for 2 hours.  Digestions were then centrifuged at 6000 x g for 5 minutes 
and the supernatants were diluted with an additional 1 mL of 5% HNO3.  Mercury content was 
determined using a Micromass Platform ICP-MS controlled by MassLynx software (Waters 
Corporation, Milford, MA).  Isotopes 
198
Hg, 
199
Hg, 
200
Hg, 
201
Hg, 
202
Hg, and 
204
Hg were recorded 
and total mercury was quantified by comparing sample responses to those produced by 
commercial standards treated identically to the samples. 
Statistical Analysis.  Differences between test groups were examined for statistical significance 
by means of one-way ANOVA followed by the Student-Neuman Keuls post-hoc analysis, with 
p<0.05 being considered significant. 
Results 
Methylmercury exposure induced concentration-dependent neurotoxicity in mixed 
neuronal and glial cortical cultures 24 hours after onset of insult (FIGURE 4.1).  Cell death was 
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assayed by release of the cytosolic enzyme lactate dehydrogenase (LDH).  Further, trypan blue 
staining of these cultures demonstrated that the MeHg-induced toxicity at the concentrations 
tested was purely neuronal (data not shown).  From these data we chose 5 μM MeHg as a 
moderate insult for subsequent experiments as it allows bidirectional alterations to MeHg-induced 
neurotoxicity (i.e. neuroprotection or potentiation).  For other experiments we used 3 μM MeHg 
as a low-level insult as no significant neurotoxicity was observed at this concentration (FIGURE 
4.1).   
MeHg toxicity has been shown to cause glutathione depletion in several cell types 
(Kitahara et al., 1993; Kaur et al., 2006; Amonpatumrat et al., 2008).  We found that exposure of 
mixed neural and glial, pure neuronal and pure glial cultures to 5 μM MeHg significantly 
decreased total GSH and disulfide glutathione (GSSG) levels in the cells as well as in the 
extracellular media (Table 1).  This glutathione depletion occurred following a 6 hour MeHg 
exposure, a time that precedes cell death as no LDH activity was detectable at this time (data not 
shown).  We next tested whether glutathione supplementation or addition of the free radical 
scavenger, trolox could protect the neurons.  24 hr co-treatment of MeHg with glutathione 
monoethyl ester (GSHME) but not trolox, was neuroprotective (FIGURE 4.2).  Since glutathione 
supplementation was protective, and this effect could be due to its nature as an antioxidant or a 
xenobiotic detoxicant, we next assessed the abilities of GSHME and Trolox to block MeHg-
induced oxidative stress. 
Mixed neuronal and glial cortical cultures exhibited a biphasic pattern of oxidative stress 
induced by exposure to 5 μM MeHg for 0, 30, 60, 180 or 360 minutes (FIGURE 4.3) as measured 
by fluorescence of DCF.  DCF fluorescence peaked at 30 minutes, returned to control levels at 3 
hours and increased once again by 6 hours following onset of MeHg insult.  Both 100 μM 
GSHME and 100 μM trolox were capable of preventing the MeHg-induced rise in DCF 
fluorescence indicative of their ability to block MeHg-induced oxidative stress.  However, trolox 
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was much more effective than GSHME actually decreasing the DCF signal well below control 
levels. 
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FIGURE 4.1.  Concentration response curve of MeHg in cortical culture.  
24-hour exposure to MeHg induces LDH release in mixed cortical cultures.  Results are 
expressed as mean+SEM (n=8-16).  * indicates significant difference from untreated control. 
 
 
 
FIGURE 4.2.  MeHg-induced neuronal death is attenuated by glutathione monoethyl ester 
(GSHME, 100 µM) but not trolox (100 µM).   
Results are expressed as mean+SEM (n=16-20).  * indicates significantly different from MeHg-
alone. 
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Table 4.1 
      Effect of MeHg (5 µM) on glutathione levels in glial, neuronal and mixed cortical 
cultures after 6 hour exposure. 
    GSH   GSSG 
Culture  Type 
 
Cellular Media   Cellular Media 
Mixed   83.4±4.7 22.8±1.0   60.7±5.7 12.6±2.4 
Glia 
 
44.8±5.2 62.3±9.8 
 
18.4±2.9 29.3±3.7 
Neurons 
 
59.6±6.5 36.9±1.8 
 
20.6±6.2 N/D 
Results are expressed as % untreated control (mean±SEM, n=8-16).  All values are 
significantly different from control. N/D = not detectable. 
 
 
 
 
FIGURE 4.3.  Timecourse of MeHg (5 µM) induced ROS formation as detected by DCF 
fluorescence.   
Results are expressed as mean+SEM (n=8-16) after normalizing to average fluorescence of 
untreated controls (i.e. DCF only). * indicates significantly different from untreated controls. 
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To further examine MeHg induced alterations to glutathione-related systems, we next 
tested whether low-level MeHg exposure had an effect on cellular uptake of cystine, the rate 
limiting substrate for GSH synthesis.  Acute exposure to MeHg had no effect on 
14
C-Cystine 
uptake (3 μM MeHg, 20 minute exposure, data not shown); however, 24-hour exposure to low-
level MeHg (3 μM) caused a robust increase in subsequent 14C-cystine uptake that was blocked 
by co-treatment with the protein synthesis inhibitor, cycloheximide (CHX, 500 ng/mL) (FIGURE 
4.4 A).  Further, this MeHg-induced increase in cystine uptake was sensitive to blockade by CPG 
(300 µM, present only during the 20 minute uptake period), an inhibitor of cystine-glutamate 
exchange (system xc
-
), suggesting that the increase was entirely mediated by functional 
upregulation of system xc-.  In a similar experiment aimed at determining the effect of trolox on 
the MeHg-induced increase, overnight exposure to trolox alone induced a large increase in 
subsequent cystine uptake (data not shown).  Thus, we used an altered protocol shortening the 
exposure time to 1 hour and followed by an overnight incubation in identical exposure media 
except lacking the experimental agents.  60 minute exposure to MeHg produced a similar increase 
in xCT-mediated cystine uptake 23 hours later (FIGURE 4.4 B).  Co-treatment with trolox 
blocked this increase while trolox alone had no effect on uptake. 
It is possible that glutathione conjugates to MeHg intracellularly and that this conjugate is 
exported via MRP1.  To test whether the export of glutathione is necessary for its protective 
capabilities, we co-treated cultures with MeHg and an inhibitor of MRP1, MK571.  MK571 alone 
caused no significant cell toxicity; however, by inhibiting MRP1-mediated glutathione export 
MeHg neurotoxicity was severely potentiated (FIGURE 4.5 A).  Supporting the idea that MeHg 
conjugates to GSH, we found that inhibiting MRP1-mediated glutathione export with MK571 led 
to a doubling of MeHg accumulation within the cellular compartment (FIGURE 4.5 B).  
Interestingly, GSH supplementation with GSHME had no effect on MeHg accumulation in the 
cells. 
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FIGURE 4.4.  Subtoxic MeHg exposure causes a robust increase in system xc
-
 mediated 
14
C-
cystine uptake.  
A- Cultures were exposed to MeHg (3 µM), cycloheximide (CHX, 500 ng/mL), or in 
combination for 24 hours prior to measuring uptake.  Carboxyphenylglycine (CPG, 300 µM) was 
present only during the 20 minute uptake period. B- Cultures were exposed to MeHg (3 µM), 
trolox (100 µM) or in combination for 60 minutes, washed into drug-free media and incubated 
overnight (23 hours) prior to assay for cystine uptake.  Results are expressed as mean+SEM (n=8-
16) after normalizing to untreated control uptake.  * indicates significantly different from control 
76 
 
FIGURE 4.5.  Blockade of glutathione efflux augments MeHg toxicity and cellular accumulation 
of mercury.   
A-Cultures were exposed to MeHg (5 µM), MK571 (10 µM), or both in combination with or 
without GSHME (100 µM) for 24 hours at which time samples were taken and neuronal death 
quantified by LDH release.  Results are expressed as mean+SEM (n=8-12). * indicates 
significantly different from untreated control, # indicates significantly different from MeHg-only 
treated.  B-Cultures were exposed to MeHg (5 µM) in the presence of GSHME (100 µM) or 
MK571 (50 µM) for 6 hours.  Samples were then taken and subsequently analyzed for mercury 
content by ICP-MS.  Results are expressed as mean+SEM (n=3-6). 
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Discussion 
The present study offers several insights into the contributions of alterations in 
glutathione cycling and oxidative stress to methylmercury-induced neurotoxicity.  We observed 
significant toxicity with overnight exposure of mixed cortical cultures to 5 μM MeHg.  This 
concentration is similar to those used in other studies demonstrating cytotoxicity, oxidative stress 
and mitochondrial deficits in cortical and cerebellar granular neuron (CGN) cultures (Gasso et al., 
2001; Morken et al., 2005; Kaur et al., 2006; Yin et al., 2007).  However, it is important to note 
that CGNs have been shown to be more sensitive to MeHg toxicity (Sarafian and Verity, 1991; 
Marty and Atchison, 1997; Sakaue et al., 2005).  Though not the only factor recognized, the 
increased sensitivity of CGNs has been posited as attributable to the relatively low glutathione 
content of these cells (Yee and Choi, 1996; Shafer et al., 2002; Kaur et al., 2007; Wang et al., 
2009). 
Previous studies have shown that MeHg causes a depletion of cellular glutathione (Yee 
and Choi, 1996; Franco et al., 2007a; Amonpatumrat et al., 2008; Wang et al., 2009).  Here, we 
also report that MeHg depletes both total and disulfide glutathione in cortical culture; total GSH 
and disulfide GSSG were decreased in cellular and media samples from glia-enriched, neuron-
enriched and mixed cultures.  This is noteworthy given the protective roles of GSH in the cell.  
GSH can reduce free radicals or eliminate exogenous molecules from the cell.  The MeHg-
induced loss of glutathione may be due to the formation of ROS and subsequent use of GSH by 
the cells to reduce the oxidative damage.  However, since reduction of oxidative stress by GSH 
results in the formation of GSSG, the observed depletion of both GSH and GSSG suggests that 
the loss of glutathione was not due to oxidative stress.  This is consistent with the hypothesis that 
glutathione is acting to detoxify MeHg by direct conjugation rendering the utilized GSH 
molecules undetectable by our assay, and perhaps unrecoverable by the cell.  It has also been 
shown that modulation of cellular thiols (including GSH) alters sensitivity to MeHg in culture 
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(Kaur et al., 2006) and that exogenous supply of glutathione precursors such as N-acetyl-cysteine 
(NAC) or cystine is neuroprotective (Fujiyama et al., 1994; Kaur et al., 2006, 2007).  Specifically, 
NAC is able to boost cellular GSH availability and leads to decreased MeHg-induced cytotoxicity 
and ROS formation.  Inhibition of glutathione synthesis with buthionine sulfoxamine (BSO) 
increases sensitivity to MeHg and increases subsequent ROS formation (Toyama et al., 2011).  
These studies also demonstrate that modulation of glutathione availability alters cellular ROS 
formation in response to MeHg insult.  Further, this ROS formation is sensitive to antioxidants 
(Gasso et al., 2001; Shanker and Aschner, 2003; Kaur et al., 2010).  Importantly, however, in our 
hands trolox does not offer the neuroprotective capacity that glutathione supplementation with 
GSHME provides.  This suggests that oxidative stress alone is not primary to the toxicity of 
MeHg under these conditions.  Others have shown that trolox does offer neuroprotection against 
early MeHg-induced mitochondrial deficits detected by MTT metabolism after short, 1 hour 
exposure (Kaur et al., 2010).  Notably, however, these studies did not investigate later timepoints 
as seen in the present data. 
We also examined the function of the cystine-glutamate antiporter in response to MeHg 
exposure by radiolabeled 
14
C-cystine uptake.  As discussed above, cystine uptake is an important 
aspect of glutathione synthesis and subsequent cycling.  Low-level MeHg insult induced a robust 
increase in cystine uptake.  This functional upregulation of xCT was blocked by CHX suggesting 
that the upregulation requires translation of new protein.  As well, CPG blocked this increased 
radioligand uptake to CPG-treated control levels suggesting the entire MeHg-induced increase 
was mediated by system xc-.  Trolox also blocked the MeHg-increased cystine uptake.  
Considering that upregulation of xCT is likely an endogenous mechanism of cytoprotection in 
response to MeHg-insult, the fact that trolox blocks upregulation of xCT may account for the 
inability of trolox to protect against the neuronal injury.  The most likely mechanism for 
increased system xc- activity is upregulation of xCT by activation of the nrf2-ARE pathway 
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(Mysona et al., 2009; Wang et al., 2009; Qin et al., 2010).  Consistent with this explanation is a 
recent report demonstrating nrf2-dependent methylmercury detoxification in hepatocytes 
(Toyama et al., 2011) and an earlier report in astrocytes (Wang et al., 2009). 
The current data indicate that blockade of oxidative stress alone is insufficient to prevent 
MeHg-induced neuronal death, and that elimination of MeHg from the cell by conjugation to 
GSH is necessary.  Consistent with this, inhibition of glutathione export via the MRP1 inhibitor, 
MK571, not only potentiated MeHg-induced neurotoxicity, but this potentiation was associated 
with increased accumulation of MeHg in the cell.  Similar results have been reported in primary 
mouse hepatocytes where it was found that upregulation of MRP1 by isothiocyanates decreased 
MeHg accumulation and toxicity (Toyama et al., 2011).  Interestingly, and consistent with a 
previous report using NAC (Kaur et al., 2006), glutathione supplementation with GSHME did not 
affect MeHg accumulation in the cell.  Trolox has previously been reported to have no effect on 
MeHg accumulation  nor on glutathione availability (Kaur et al., 2010); these and the present 
data, support the assertion that oxidative stress is not primary to MeHg-induced neurotoxicity.  
Rather, conjugation with MeHg and subsequent export of glutathione from the cytosol is crucial 
to alleviate or prevent MeHg-induced neurotoxicity and that solely blocking oxidative stress is 
not likely to offer significant neuroprotection. 
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SYNERGISTIC TOXICITY OF THE ENVIRONMENTAL NEUROTOXINS 
METHYLMERCURY AND BMAA 
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Abstract 
Determining the environmental factors involved in neurodegenerative diseases has been 
elusive.  Methylmercury and β-N-methylamino-L-alanine (BMAA) have both been implicated in 
this role.  However, studying these factors in isolation probably does not accurately mimic the 
human condition.  Neurodegenerative diseases likely involve a complex interaction between 
genetic predisposition and multiple environmental factors.   In the current study we tested the 
interaction of the environmental neurotoxins methylmercury and BMAA.   Exposure of primary 
cortical cultures to methylmercury or BMAA independently induced concentration dependent 
neurotoxicity.  Importantly, concentrations of BMAA that caused no toxicity by themselves 
potentiated methyl mercury toxicity.  Since both BMAA and methylmercury toxicity have been 
associated with depletion of glutathione we examined the role of glutathione in the combined 
toxicity.  BMAA plus methylmercury, at concentrations that had no effect by themselves, induced 
depletion of cellular glutathione.  The combined toxicity of methylmercury and BMAA was 
attenuated by the cell permeant form of glutathione, glutathione monoethyl ester, and the free 
radical scavenger, trolox, but not by the NMDA receptor antagonist, MK-801. The results 
indicate a synergistic toxic effect of the environmental neurotoxins BMAA and methyl mercury 
and that the interaction is at the level of glutathione depletion.  Since glutathione depletion is 
known to occur in neurodegenerative diseases these results provide a potential mechanism for the 
involvement of methylmercury and BMAA in neurodegenerative diseases. 
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Introduction 
The cause of most neurodegenerative diseases is unclear.  Huntington‟s disease is a 
purely genetic disease, but Alzheimer‟s disease, Parkinson‟s disease, and amyotrophic lateral 
sclerosis (ALS) involve varying degrees of genetic and environmental factors.  The exact role of 
environmental factors, and what those factors are, has been difficult to determine.  Two of the 
environmental factors that have been implicated in the etiology of neurodegenerative diseases are 
β-N-methylamino-L-alanine (BMAA) and methylmercury.   
BMAA is a non-protein amino acid neurotoxin that was first implicated in the 
neurodegenerative disease ALS/ Parkinson‟s Dementia Complex (ALS/PDC) on Guam (Cox and 
Sacks, 2002; Papapetropoulos, 2007).   Since these initial reports, a number of studies have 
suggested that BMAA may be involved in neurodegenerative diseases, not only on Guam, but 
also in the rest of the world.  First, cyanobacteria present throughout the world have been shown 
to produce BMAA (Cox et al., 2005; Banack et al., 2007; Esterhuizen and Downing, 2008; 
Metcalf et al., 2008).  Second, BMAA is biomagnified in systems not only on Guam (Cox et al., 
2003), but also in the Baltic Sea (Jonasson et al., 2010) and the Gulf of Mexico (Brand et al., 
2010).  Third, BMAA can become protein-associated which allows for it to build up in tissue and 
provides a mechanism for slow release (Murch et al., 2004a).  Forth, BMAA was found not only 
in brain samples of ALS/PDC patients from Guam, but also in the brains of Alzheimer‟s disease 
and ALS patients from North America (Murch et al., 2004b; Pablo et al., 2009).   These results 
suggest that BMAA may be of concern not only for people on select pacific islands, but is a 
general health concern for the world population.   
Mercury exposure to humans occurs primarily in the forms of elemental mercury, 
ethylmercury, or methylmercury.  Elemental mercury exposure can come from dental amalgam.  
Mercury vapor is released from amalgam restorations (Clarkson, 1997) and a strong correlation 
between the level of mercury exposure and poor performance on motor and cognitive tests was 
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found in dentists (Ngim et al., 1992).  However, with modern dental materials, and proper 
handling of amalgam by dental professionals, this problem can be minimized and there is no 
evidence that the number of amalgam fillings is correlated with cognitive performance (Saxe et 
al., 1995).  Ethylmercury, often in the form of the compound thimerosal, is present as a 
preservative in a number of products, including vaccines.  It has been reported that thimerosal 
containing vaccines play a causal role in the development of autism (Mutter et al., 2004), but 
there is no clear evidence for such a connection (Aschner and Ceccatelli, 2010).  Methylmercury 
exposure to humans is widespread.  Methylmercury is formed through the methylation of 
inorganic mercury by bacteria in aquatic sediment (Clarkson, 1997).  It is found at high levels in 
many fish and shellfish (Mahaffey et al., 2004).  It is clear that exposure to high levels of 
methylmercury can induce neurological deficits.  For example, a large industrial release of 
methylmercury into Minamota Bay in Japan led to high levels of methylmercury exposure and 
severe injury to the population, including neurological deficits (Harada, 1995).  There is some 
evidence that methylmercury at lower concentrations can cause neurological problems.  The best 
evidence comes from studies showing that exposure to even low levels of methylmercury 
prenatally can cause neurological deficits (Grandjean et al., 1998).  However, fairly low exposure 
of methylmercury to adults has also been shown to induce neurological deficits (Yokoo et al., 
2003).  It is important to note that methylmercury is more easily absorbed into the body than 
other forms of mercury (Bains and Shaw, 1997).  Furthermore, methylmercury crosses the blood 
brain barrier as a complex with cysteine (Kerper et al., 1992) and the main form of 
methylmercury found in fish is as a complex with cysteine (Harris et al., 2003). 
 One problem with most studies involving environmental neurotoxins is that they have 
typically been studied in isolation, while the actual situation clearly involves interaction between 
multiple toxins and genetic factors.  As a first step to assess how such factors may interact we 
studied the interaction of BMAA and methyl mercury.  
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Materials and Methods 
Materials.   
Timed pregnant Swiss Webster mice were obtained from Charles River Laboratories 
(Wilmington, DE, USA).  Serum was from Atlanta Biologicals (Atlanta, GA).  Trolox and 
glutathione monoethyl ester were from Calbiochem (San Diego, CA).  All other chemicals were 
obtained from Sigma (St. Louis, MO).  
 
Cortical cell cultures.   
Mixed cortical cell cultures containing neuronal and glial cells were prepared from fetal 
(15-16 day gestation) mice as previously described (Lobner, 2000).  Dissociated cortical cells 
were plated on 24 well plates coated with poly-D-lysine and laminin in Eagles‟ Minimal Essential 
Medium (MEM, Earle‟s salts, supplied glutamine-free) supplemented with 5% heat-inactivated 
horse serum, 5% fetal bovine serum, 2mM glutamine and glucose (total 21 mM).  Cultures were 
maintained in a humidified 5% CO2  incubator at 37°C.  Mice were handled in accordance with a 
protocol approved by our institutional animal care committee. 
 
Induction of neuronal death.   
All experiments were performed on mixed cultures 13-15 days in vitro (DIV).  Toxicity 
was induced by exposure to the toxic agents for 24 hours in media as described for plating except 
without serum.  All exposure media contained 26 mM NaHCO3, as it has been shown previously 
that HCO3- is required for expression of NMDA receptor mediated BMAA toxicity (Weiss and 
Choi, 1988). 
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Assay of neuronal death (LDH Release).   
Cell death was assessed in mixed cultures by the measurement of lactate dehydrogenase 
(LDH), released from damaged or destroyed cells, in the extracellular fluid 24 hours after the 
beginning of the insult.  Blank LDH levels were subtracted from insult LDH values and results 
normalized to 100% neuronal death caused by 500 mM NMDA.  Control experiments have 
shown previously that the efflux of LDH occurring from either necrotic or apoptotic cells is 
proportional to the number of cells damaged or destroyed (Koh and Choi, 1987; Lobner, 2000).   
Glial cell death (assessed by trypan blue staining) was not observed in any of the current studies.  
Therefore results are presented as percent neuronal death. 
  
Glutathione assay.   
Total glutathione was assayed using a modification of a previous method (Baker et al., 
1990; Lobner et al., 2003).  Briefly, following exposure to BMAA and/or methylmercury for 6 
hours, cells were washed with a HEPES buffered saline solution, dissolved in 200 µl of 1% 
sulfosalicylic acid, and centrifuged.  A 25 µl aliquot of the supernatant was combined with 150 µl 
of 0.1 M phosphate/5 mM EDTA buffer, 10 µl of 20 mM dithiobis-2-nitrobenzoic acid, 100 µl of 
5 mM NADPH, and 0.2 U of glutathione reductase.  Total glutathione was determined by kinetic 
analysis of absorbance changes at 402 nm for 1.5 minutes, with concentrations determined by 
comparison to a standard curve.  
 
Statistical analysis. 
Differences between test groups were examined for statistical significance by means of  
one-way ANOVA followed by the Bonferroni correction post-hoc test, with p<0.05 being 
considered significant. 
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Results 
 Methylmercury and BMAA both induced concentration dependent neurotoxicity in 
mixed neuronal and glial cortical cell cultures (FIGURE 5.1 A and B).  Cell death was assayed by 
release of the cytosolic enzyme lactate dehydrogenase (LDH).  The toxicity at these 
concentrations was purely neuronal as assessed by trypan blue staining (data not shown).  We 
next tested for a synergistic interaction between BMAA and methylmercury by testing the effects 
of sublethal concentrations of BMAA on low level toxicity induced by 3 µM methylmercury.  
BMAA at concentrations from 10-100 µM causes potentiation of the methylmercury toxicity 
(FIGURE 5.2). 
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FIGURE 5.1.  Concentration dependent toxicity of methylmercury and BMAA in cortical 
cultures.   
Bars show % neuronal cell death (mean + s.e.m., n=16-20) quantified by measuring release of 
LDH, 24 hrs after the beginning of the insult.  * indicates significant toxicity.   
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FIGURE 5.2.  Synergistic toxicity of BMAA and methylmercury.   
BMAA at concentrations that do not cause any toxicity by themselves (10-100 µM) significantly 
potentiate methylmercury (3 µM) toxicity.   Bars show % neuronal cell death (mean + s.e.m., 
n=16-20) quantified by measuring release of LDH, 24 hrs after the beginning of the insult.   *  
indicates significant difference from methylmercury alone. 
 
 Both BMAA and methylmercury toxicity have been associated with disruption of the 
glutathione system (Kaur et al., 2006; Liu et al., 2009).  We found that, at relatively low 
concentrations, 100 µM BMAA and 3 µM methylmercury, they do not cause significant depletion 
of cellular glutathione.  However, the two toxicants administered together did cause significant 
glutathione depletion (FIGURE 5.3).  The glutathione assays were performed at the end of 6 hour 
exposure to the toxins, a time before significant cell death occurred (less than 10% measured by 
LDH release). 
 Toxicity caused by a high concentration of BMAA is mediated primarily by activation of 
NMDA receptors, with oxidative stress apparent when NMDA receptors are blocked (Lobner et 
al., 2007).   Toxicity of higher concentration methylmercury in this culture system is attenuated 
by the cell permeant form of glutathione, glutathione monoethyl ester, but not by the free radical 
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scavenger, trolox (Rush et al., 2010).  The combined toxicity of low level methylmercury and 
BMAA was not attenuated by the NMDA antagonist MK-801, but was attenuated by trolox or 
glutathione monoethyl ester (FIGURE 5.4). 
 
 
 
 
FIGURE 5.3.  Methylmercury plus BMAA, but not either compound alone, significantly 
decreases cellular glutathione.  
Methylmercury (3 µM), BMAA (100 µM). Bars show glutathione levels following a 6 hour 
exposure presented as % Control (mean + s.e.m., n = 16).  *  indicates significant difference from 
control. 
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FIGURE 5.4.  Synergistic toxicity of BMAA and MeHg is dependent on oxidative stress. 
Synergistic toxicity of BMAA and methylmercury is not attenuated by the NMDA antagonist 
MK-801, but is attenuated by the free radical scavenger trolox, and the cell permeant form of 
glutathione, glutathione monoethylester. Methylmercury (3 µM), BMAA (100 µM), MK-801 (10 
µM), Trolox (100 µM), GSHME (100 µM). Bars show % neuronal cell death (mean + s.e.m., 
n=16-20) quantified by measuring release of LDH, 24 hrs after the beginning of the insult.   * 
indicates significant toxicity.  # indicates significant difference from BMAA plus methylmercury 
without drug treatment. 
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Discussion 
There are two main findings of the current study.  First, there is a synergistic toxicity 
between methylmercury and BMAA.  Second, the mechanism of the synergistic toxicity appears 
to be at the level of depletion of cellular glutathione.  Depletion of glutathione as the mechanism 
of combined methylmercury and BMAA toxicity is consistent with the known actions of each of 
the compounds. We have shown previously that high concentration BMAA inhibits 
cystine/glutamate exchange-mediated cystine uptake leading to decreased cellular glutathione 
(Lobner et al., 2007).  The prominent role of cystine/glutamate exchange in the regulation of 
cellular glutathione and how its inhibition can lead to neuronal death has been well characterized 
(Murphy and Baraban, 1990).  The process of glutathione production in neurons involves a 
complex series of steps in which cystine is taken up primarily into astrocytes (Sagara et al., 
1993).  The glutathione produced by astrocytes is released and converted extracellularly into 
cysteine, which is taken up by neurons and used by them to produce glutathione (Wang and 
Cynader, 2000).  
 BMAA acts to specifically block the initial step of uptake of cystine into astrocytes 
(Lobner, 2009; Liu et al., 2010).  Methylmercury can act at a number of levels on the glutathione 
system.  It has been shown to inhibit glutathione peroxidase (Franco et al., 2009) and can directly 
conjugate to glutathione (Fujiyama et al., 1994).  The combination of the effects on the 
glutathione system by BMAA and methylmercury could potentially cause neurodegeneration.  
There is evidence that glutathione depletion plays a role in Alzheimer‟s disease, Parkinson‟s 
disease, and ALS (Bains and Shaw, 1997; Liu et al., 2004; Zeevalk et al., 2008).  The type of low 
level, long-term, depletion of glutathione that may be caused by exposure to methylmercury and 
BMAA could cause the long-term oxidative stress that may underlie aspects of neurodegenerative 
diseases.  
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The toxicity of the combination of methylmercury and BMAA is somewhat different 
from the toxicity of either compound by itself at higher concentrations.  Toxicity of a high 
concentration of BMAA is mediated primarily by NMDA receptor activation, with significant 
protection provided by the NMDA receptor antagonist MK-801, and protection by trolox only 
occurring when NMDA receptors are blocked (Lobner et al., 2007).  Neurotoxicity of 
methylmercury is sensitive to manipulations that increase intracellular glutathione (Kaur et al., 
2006; de Melo Reis et al., 2007).  The effects of trolox are less clear.  The oxidative stress 
induced by methylmercury is decreased by trolox (Shanker and Aschner, 2003), but trolox does 
not prevent the toxicity (Kaur et al., 2010), and specifically does not prevent the toxicity in our 
culture system (Rush et al., 2010).  The combined toxicity of low level BMAA and 
methylmercury is not sensitive to MK-801, but is attenuated by either glutathione ethyl ester or 
trolox.  This result indicates the prominence of oxidative stress in the toxicity of combined 
treatment. 
Is exposure to both BMAA and methylmercury likely to occur in the same person?  The 
simple answer is that since both are ubiquitous in the environment it is likely that exposure to 
both will occur in many people.  The ability to answer the more specific question of whether 
exposure to both will occur through the consumption of certain fish or shellfish from specific 
locations is limited by the available information.  BMAA levels in certain type of fish and 
shellfish species have only been measured in two location: the Baltic Sea (Jonasson et al., 2010) 
and southern Florida (Brand et al., 2010).  Certain trends appear in this data.  The highest levels 
of BMAA appear to be found in filter feeders such as shellfish.  This is different than the 
methylmercury which accumulates more higher up the food chain.  However, there is some 
overlap.  For example, in the Caloosahatchee river in Florida, fish such as largemouth bass,  and 
bowfin have high levels of BMAA (Brand et al., 2010), and these same fish have also been shown 
to accumulate mercury (Katner et al., 2010).  The Caloosahatchee River specifically has been 
shown to have high levels of mercury in its sediment and the one fish type tested, catfish, had 
93 
high mercury levels (Kannan et al., 1998). Interestingly, high levels of both BMAA and 
methylmercury have been found in the brains of deceased Alzheimer‟s disease patients (Hock et 
al., 1998; Pablo et al., 2009).  Of course exposure to BMAA and methylmercury does not have to 
come from the same source and more studies of levels of BMAA in various systems must be 
performed.    
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CHAPTER VI 
 
 
 
 
 
 
 
 
 
GENERAL DISCUSSION 
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General Discussion 
The data presented in this thesis not only provide valuable insights into the etiology of 
several environmental toxicants but also lay an important framework for studying potential 
interactions of toxicants likely to be coexposed and have overlapping targets leading to 
augmented (neuro)toxicity.  This final section presents a discussion of the major findings from 
the presented studies as well as that of the broad implications thereof.  Included is a discussion of 
the impact of future research derived from these studies. 
Organophosphorous Pesticides 
 One of the most significant findings of this study was the observation that both 
chlorpyrifos and diazinon can cause neurotoxicity by distinct mechanisms and each independent 
of acetylcholinesterase inhibition.  Whereas CPF was shown to elevate extracellular glutamate 
and cause an excitotoxic necrosis, DZN produced an apoptotic neurodegeneration by a yet to be 
determined mechanism.  These findings contrast with the major theory that OP agent-induced 
neurotoxicity results from AChE inhibition and subsequent cholinergic hyperstimulation.  
However, recent interest in OP chemicals has shifted to studies such as mine. 
One such in vitro study demonstrated CPF as toxic to oligodendrocyte precursors by a 
mechanism that was insensitive to antagonists of cholinergic receptors (Garcia et al., 2001; 
Garcia et al., 2002).  While this study did not suggest a prominent role for glutamatergic 
excitotoxicity as seen in my study, but rather an oxidative stress-induced cell death, it is not in 
direct conflict with my data because of the difference in cultured cell types utilized.  My studies 
were performed using cortical neurons cultured with glia (mostly astrocytes).  Quantified cell 
death was composed entirely of neurons and suggested to be a result of AMPA and NMDA 
receptor stimulation by the elevated glutamate levels in the extracellular media.  It is likely that 
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neurons, by their electrically excitable nature, are sensitive to this mechanism of CPF action.  The 
oligodendrocyte progenitors from the Garcia study, on the other hand, are far less excitable and 
thus, less likely to be susceptible to excitotoxic stimulation.  Interestingly, there have been reports 
of CPF-induced apoptosis in other non-excitable cell types such as human T lymphocytes (Li et 
al., 2007, 2009).  In vitro and in vivo evidence suggests that damage to these immune cells leads 
to immunological abnormalities including an association with increased allergies in animals and 
humans (Thrasher et al., 1993; Blakley et al., 1999; Thrasher et al., 2002). 
Further support for CPF having glutamatergic effects comes from genetic microarray 
data.  CPF and DZN at concentrations unlikely to cause significant inhibition of AChE were 
demonstrated to cause transcriptional alterations in rats (Slotkin and Seidler, 2007, 2010).  
Specifically, CPF increased transcription of glutamate receptor proteins (of specific note, the 
calcium-permeable NMDA receptor subunit, NR2B) and later shown to alter glutamate 
transporter expression.  This may suggest a bimodal mechanism that could account for the CPF-
induced glutamatergic hyperstimulation I observed.  That is, by CPF increasing ionic glutamate 
receptors the cultured neurons would become more sensitive to the elevated glutamate 
concentrations resulting from decreased glutamate transporter expression.  My results are 
consistent with both microarray findings for CPF.  Also consistent with my data were the DZN 
findings from the microarray study.  In particular, DZN was reported to increase apoptosis related 
genes (i.e. Caspases) to a greater degree than CPF.  DZN did not alter expression of glutamate 
receptors or transporters (Slotkin et al., 2010).  Of course, further experiments are necessary to 
confirm these suggestions as relevant to CPF and DZN-induced neurotoxicity in vitro and in vivo. 
Importantly, these results highlight the potential for OP agents to act beyond their 
anticholinesterase actions.  The likelihood that other OP compounds exert non-cholinergic actions 
is great and this is underlined by the finding that CPF and DZN both can cause neurotoxicity by 
distinct, non-cholinergic mechanisms.  There are other recent reports suggesting that other non-
cholinergic mechanisms exist for OP nerve agents sarin, VX and tabun, as well (Chebabo et al., 
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1999; Rocha et al., 1999).  While cholinergic hyperstimulation is obviously key to the acute 
lethality of these compounds, non-cholinergic mechanisms are likely to contribute, at least in part, 
to the ability of OP agents to increase the risk of developing neurodegenerative disease.  Further 
study along this avenue is imperative to understand, and if possible address, the risks associated 
with OP exposure. 
Heavy Metals 
Chelation 
One potentially worrying finding with regard to my studies is that every chelator 
examined exacerbated the damage caused by at least one heavy metal, and several of the chelators 
tested potentiated more than one metal.  DPA had the most detrimental effects in our hands, in 
that it potentiated the damage of inorganic mercury, thimerosal and iron while failing to provide 
protection from any of the metals tested.  That said, EDTA, DMPS and DMSA each provided 
near complete protection against inorganic mercury.  These data suggest that it is potentially very 
important to consider which metals may be present in a patient when selecting a chelator in order 
to at least avoid further damage.  There are certain key limitations to this study, such that clinical 
applications of these chelators may produce less obvious effects.  Specifically, the renal system 
would, in theory, remove the chelated metal complex perhaps before any further damage could be 
done.  Our data suggests that without targeting any specific heavy metal, but rather, targeting 
multiple metal species with a single chelator is likely to potentiate the insult caused by at least 
one other metal likely to be present.  While my study did not investigate the exact nature of the 
potentiating effects of these metal chelates, others have provided similar evidence in the past.  For 
instance, EDTA has been shown to improve the ability of iron to catalyze the Fenton reaction 
producing excessive ROS.   
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Mercury toxicity 
Perhaps the most important contribution I made with regard to the neurotoxicity of 
mercurials is the clarification that oxidative stress is not the primary mechanism underlying the 
toxicity of these compounds.  In fact, the data suggest that at least the early increase in ROS 
production following onset of mercurial insult is important to activation of an endogenous 
cytoprotective mechanism involving system xc
-
 and glutathione.  The evidence for this is the lack 
of protection by the antioxidants trolox and PBN against MeHg insult; and the potentiation of 
inorganic mercury- or thimerosal-induced toxicity by these antioxidants. 
My experiments exploring the role of glutathione in the detoxification of mercurials also 
provided evidence to support a secondary role for oxidative stress.  While many other studies 
have reported a depletion of glutathione in response to inorganic mercury, methylmercury or 
thimerosal, my data provides a more complete picture.  Specifically, I have demonstrated that 
each of these mercurials depletes total glutathione as well as disulfide glutathione in cellular and 
extracellular compartments across all three culture types: mixed cortical neurons and glia, glia-
enriched and neuron-enriched.  The most likely explanation is that the mercurials, with their high 
affinity for sulfhydryl interactions, conjugate directly to any available glutathione thereby 
removing glutathione from the cycling pool and rendering it undetectable by our assay.  
Supporting this hypothesis is evidence from several mass-spectrometry studies demonstrating that 
mercurials directly conjugates with glutathione and its cysteinyl precursors.   
Another important finding was the obligate role of the glutathione exporter, MRP1, in the 
detoxification of mercurials.  Inhibiting MRP1-mediated export with MK571 produced a severe 
potentiation of mercurial-induced neurotoxicity.  While glutathione supplementation is well-
known to protect against mercury insult, inhibition of MRP1 eliminated the protective effects of 
glutathione supplementation.  Further analysis demonstrated that in the face of methylmercury 
insult, preventing the export of glutathione nearly doubled the amount of cell-associated mercury 
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measured by inductively-coupled plasma mass spectrometry.  While others have reported similar 
findings with regard to a detoxifying role for glutathione (Toyama et al., 2007; Wang et al., 
2009), this study is the first to clearly demonstrate an obligate role for MRP1-mediated export in 
this detoxification. Only one recent study has produced similar findings, and have actually 
provided a more complete story (Toyama et al., 2011).  In this study, researchers targeted 
upregulation of genes under the control of the transcription factor NRF2 as a means of increasing 
cellular defense against methylmercury insult in mouse hepatocytes and a neuronal cell line.  By 
exposing mice to isothiocyanate compounds, NRF2-regulated genes which include system xc
-
, 
MRP1, and glutathione sythesizing enzymes were upregulated.  This upregulation decreased 
subsequent mercury burden in an MK571-dependent manner in hepatocytes cultured from these 
mice and SH-SY5Y cells treated similarly.   
I propose here that cytosolic glutathione conjugates with mercury that has gained access 
to the intracellular compartment and is subsequently exported by MRP1 preempting the metal‟s 
damaging effects.  When the cell first detects mercury, likely through a ROS-sensing NRF2-
dependent mechanism, or perhaps through a loss of glutathione, a signaling mechanism shown 
recently in a similar culture system, the cell responds by upregulating NRF2-responsive genes in 
order to maintain glutathione levels (Seib et al., 2011).  Of course, if the mercury remains at high 
levels for prolonged periods, such as in our culture conditions, eventually this system is 
overwhelmed and the neurons die.  With an exogenous supply of glutathione or its precursors, the 
cell can better maintain intracellular glutathione available for the detoxification of mercury and 
neurodegeneration is prevented (Zeevalk et al., 2007).  However, an alternate explanation for 
protection with glutathione supplementation is that the glutathione symply provides an abundance 
of sulfhydryl groups with which the mercurials can interact without causing any cellular damage.  
While this is possible, data from my current study argue against it.  First, glutathione 
supplementation does not, by itself, alter the amount of mercury associated with the cell, despite 
its ability to protect against mercurial insult.  This by itself may actually speak to the hypothesis 
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that abundant sulfhydryl groups account for glutathione-mediated protection.  However, the 
second piece of data demonstrates that the same glutathione supplementation fails to protect 
against mercury toxicity when MRP1-mediated glutathione export is inhibited.  This finding 
suggests that availability of the sulfhydryl groups of glutathione has little to do with its protection 
against methylmercury toxicity.  An important measure that may clarify this point is one that has 
not been made.  It would be useful to know whether cell-associated mercury content remains 
doubled in the presence of MK571 when glutathione is supplied exogenously.  FIGURE 6.1 
depicts the working model of MeHg neurotoxicity as it relates to glutathione cycling. 
101 
 
FIGURE 6.1.  MeHg effects on GSH cycling.   
Upon accessing the cytosolic compartment, MeHg is able to conjugate to free mono-sulfide 
glutathione (GSH) via suflydryl bond.  Glutathione conjugation to MeHg leads to a depletion of 
GSH available for homeostatic use as an antioxidant.  Once conjugated, the MeHg-GSH complex 
is exported from the cell via MRP-1, thereby limiting the damaging effects of MeHg.  However, 
depletion of GSH may lead to accumulation of free-radicals produced endogenously or by some 
mechanism induced by MeHg in/directly.  MeHg has other well-defined damaging effects, 
namely disruption of calcium and zinc ion homeostasis. 
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Combinatorial Neurotoxicity 
 The major finding from my studies of MeHg and BMAA was the identification of their 
convergence on the glutathione system.  While these agents are neurotoxic by themselves at 
relevant concentrations, of greater concern is that these toxicants can act synergistically to cause 
significant cell death at concentrations that are not toxic in isolation.  Specifically, the data 
suggest that MeHg, at a concentration that does not cause neuronal death, becomes neurotoxic 
when paired with a concentration of BMAA that is also not toxic by itself.  Given that previous 
research in the Lobner lab has demonstrated that both of these compounds can adversely affect 
the glutathione system, the hypothesis is that MeHg and BMAA act synergistically by attacking 
separate arms of the glutathione cycle.  Indeed, when MeHg and BMAA insults were combined, 
cellular glutathione levels were depleted, an effect not seen with either compound alone at these 
relatively low concentrations.  The combined exposure was necessary to induce neurotoxicity, 
and the toxicity was blocked by application of the antioxidant trolox or by glutathione 
supplementation. This suggests that oxidative stress and glutathione depletion play key roles in 
the toxicity induced by these two toxicants.  A model of combined exposure can be seen in 
FIGURE 6.2. 
 Since each of these agents has been implicated in the etiology of neurodegenerative 
disease (i.e. AD, PD and ALS/ALS-PDC) and exposure to more than one of these compounds is 
increasingly likely due to their ubiquity and overlapping routes of exposure, it is important that 
their effects are understood in combination.  This study is a platform for future work with these 
compounds.  Of course, MeHg and BMAA are not the only toxic compounds present in the 
environment.  MeHg and BMAA are also not the only environmental neurotoxicants that disrupt 
the glutathione system or cellular redox state.  Genetic factors, many of which are implicated in 
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sporadic neurodegenerative diseases, are also known to negatively impact these measures.  Thus, 
many factors (i.e. multiple environmental toxicants and genetic factors) may converge in an 
immensely complicated manner to produce a cell-type specific disease.  While studies must 
eventually be designed to demonstrate these complicated interactions, the data within this thesis 
contribute important first steps in identifying cellular targets common to environmental toxicants 
and demonstrating a proof of principle synergistic action by exploiting these targets.   
Others have previously investigated the mechanism(s) of other neurotoxicants likely to be 
co-exposed.  Polychlorinated biphenyls (PCBs) are also found in fish.  Low-dose exposures to 
PCBs and MeHg during periods of development are now recognized to cause long-term 
neurological deficits (Vitalone et al., 2010).  Iron and paraquat act synergistically to cause death 
of dopaminergic neurons of the substantia nigra, perhaps leading to increased likelihood of 
developing PD in individuals co-exposed to these toxicants (Peng et al., 2010).  Recent studies 
have demonstrated that arsenic and fluoride are often both present in water supplies, and have 
begun investigating neurotoxic mechanisms of these compounds in combination (Chouhan and 
Flora, 2010).  While many of these studies are quite recent, the scientific community has long 
recognized the impact of exposure to multiple toxins.  Early studies examined combined exposure 
of high manganese levels and ethanol (Shukla et al., 1978), or multiple pesticides in factory 
workers producing these products (Peters et al., 1986).  Another important new prospect in this 
direction is that of combining environmental factors with genetic susceptibilities suspected as risk 
factors for disease.  An important first study in this area found that chronic, low-dose exposure to 
dietary MeHg hastened the onset and progression of ALS-like symptoms in the SOD1-G93A rat 
model of ALS (Johnson et al., 2011).  It is expected that more studies will appear in the near 
future providing enormous insight into the etiology of these debilitating disease. 
The next logical steps will involve research designed to extend our understanding of the 
role of environmental and genetic factors that can lead to neurodegenerative disease.  These 
studies should include combinations of two and more environmental toxicants on wild-type in 
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vitro and in vivo models.  In vivo studies of combined environmental toxicants in wild-type and 
genetically predisposed animal models (such as SOD1-G93A rodents) should also be conducted.   
Epidemiological studies to identify genetically susceptible populations also exposed to 
environmental toxicant(s) would be immensely helpful in understanding these relations.  The data 
presented in this thesis provide evidence suggesting environmental exposures to toxicants in 
isolation or in combination, may compromise neuronal health and potentially lead to development 
of neurodegenerative disease. 
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FIGURE 6.2. Combined effects of MeHg and BMAA on GSH cycling. 
MeHg and BMAA both impact glutathione cycling leading to synergistic enabling of individual 
toxic effects.  By competing for cystine import via system xc
-
, BMAA decreases glutathione 
production thereby rendering neurons and astrocytes more susceptible to MeHg.  Additionally, 
simultaneous stimulation of NMDA receptors by BMAA directly and stimulation of metabotropic 
glutamate receptors (mGluR 5) by glutamate released via system xc
-
 in exchange for BMAA and 
cystine exacerbates the calcium and zinc dishomeostasis imposed by MeHg. 
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TABLE OF ABBREVIATIONS 
Table of Abbreviations 
AC adenylyl cyclase 
ACh acetylcholine 
AChE acetylcholinesterase 
AD Alzheimer's Disease 
ALS Amyotrophic Lateral Sclerosis 
ALS-PDC Amyotrophic Lateral Sclerosis-Parkinson's-like Dimentia Complex 
AO antioxidant 
APV D-2-amino-5-phosphovaleric acid 
ASChI acetylthiocholine iodide 
BBB blood-brain barrier 
BMAA beta-N-methylamino-L-alanine 
CaNa2EDTA calcium disodium ethylenediaminetetraacetate 
CGN cerebellar granular neuron 
CHX cycloheximide 
CNS central nervous system 
CPF chlorpyrifos 
CPG S-(4)-carboxyphenylglycine 
CPO chlorpyrifos-oxon 
CysGly cysteinylglycine 
DCF dichlorodihydrofluorescein 
DIV day in vitro 
DMPS 2,3-dimercaptopropane-1-sulfonate 
DMSA dimercaptosuccinic acid 
DPA D-penicillamine 
DZN diazinon 
DZO diazinon-oxon 
EAAT excitatory amino acid transporter 
GFAP glial fibrillary acidic protein 
GSH glutathione 
GSHME glutathione monoethyl ester 
GSSG glutathione (disulfide) 
GST glutathione-S-transferase 
GSx glutathione conjugates 
LDH lactate dehydrogenase 
MeHg methylmercury 
MRP-1 multidrug resistance protein-1 
NAC N-acetylcysteine 
NBQX 6,7-dinitroquinoxaline-2,3-dione 
NRF2-ARE nuclear factor (erythroid derived-2)-like 2-antioxidant response element 
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OP organophosphorous pesticides 
OPIDP organophosphate-induced delayed polyneuropathy 
PBN N-phenyl-2-naphthylamine 
PCBs polychlorinated biphenyls 
PD Parkinson's Disease 
PITC phenylisothiocyanate 
ROS reactive oxygen species 
TCP 3,5,6-trichloropyridinol 
TEA triethylamine 
ZVAD Z-Val-Ala-Asp-fluoromethylketone 
 
 
